<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Imaging modalities for characterising focal pancreatic lesions - Best, LMJ - 2017 | Cochrane Library</title> <meta content="Imaging modalities for characterising focal pancreatic lesions - Best, LMJ - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010213.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Imaging modalities for characterising focal pancreatic lesions - Best, LMJ - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010213.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010213.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Imaging modalities for characterising focal pancreatic lesions" name="citation_title"/> <meta content="Lawrence MJ Best" name="citation_author"/> <meta content="Royal Free Campus, UCL Medical School" name="citation_author_institution"/> <meta content="Vishal Rawji" name="citation_author"/> <meta content="University College London Medical School" name="citation_author_institution"/> <meta content="Stephen P Pereira" name="citation_author"/> <meta content="Royal Free Hospital Campus" name="citation_author_institution"/> <meta content="Brian R Davidson" name="citation_author"/> <meta content="Royal Free Campus, UCL Medical School" name="citation_author_institution"/> <meta content="Kurinchi Selvan Gurusamy" name="citation_author"/> <meta content="Royal Free Campus, UCL Medical School" name="citation_author_institution"/> <meta content="k.gurusamy@ucl.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD010213.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/04/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010213.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010213.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010213.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Diagnostic Imaging [*methods]; Elasticity Imaging Techniques; Endoscopic Ultrasound‐Guided Fine Needle Aspiration; Endosonography; Magnetic Resonance Imaging; Pancreatic Diseases [diagnostic imaging]; Pancreatic Neoplasms [*diagnostic imaging]; Positron‐Emission Tomography; Precancerous Conditions [*diagnostic imaging]; Sensitivity and Specificity; Tomography, X‐Ray Computed" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010213.pub2&amp;doi=10.1002/14651858.CD010213.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="Ko3zGe0H";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010213\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010213\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010213.pub2",title:"Imaging modalities for characterising focal pancreatic lesions",firstPublishedDate:"Apr 17, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Ko3zGe0H&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010213.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010213.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010213.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010213.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010213.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010213.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010213.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010213.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010213.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010213.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2843 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010213.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-sec-0081"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-sec-0037"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-sec-0039"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-sec-0057"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-sec-0077"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/appendices#CD010213-sec-0086"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/table_n/CD010213StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/table_n/CD010213StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Diagnostic</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Imaging modalities for characterising focal pancreatic lesions</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#CD010213-cr-0002">Lawrence MJ Best</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#CD010213-cr-0003">Vishal Rawji</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#CD010213-cr-0004">Stephen P Pereira</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#CD010213-cr-0005">Brian R Davidson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information#CD010213-cr-0006"><i class="icon corresponding-author fa fa-envelope"></i>Kurinchi Selvan Gurusamy</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information/en#CD010213-sec-0093">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 April 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010213.pub2">https://doi.org/10.1002/14651858.CD010213.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010213-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010213-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010213-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010213-abs-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010213-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010213-abs-0001" lang="en"> <section id="CD010213-sec-0001"> <h3 class="title" id="CD010213-sec-0001">Background</h3> <p>Increasing numbers of incidental pancreatic lesions are being detected each year. Accurate characterisation of pancreatic lesions into benign, precancerous, and cancer masses is crucial in deciding whether to use treatment or surveillance. Distinguishing benign lesions from precancerous and cancerous lesions can prevent patients from undergoing unnecessary major surgery. Despite the importance of accurately classifying pancreatic lesions, there is no clear algorithm for management of focal pancreatic lesions. </p> </section> <section id="CD010213-sec-0002"> <h3 class="title" id="CD010213-sec-0002">Objectives</h3> <p>To determine and compare the diagnostic accuracy of various imaging modalities in detecting cancerous and precancerous lesions in people with focal pancreatic lesions. </p> </section> <section id="CD010213-sec-0003"> <h3 class="title" id="CD010213-sec-0003">Search methods</h3> <p>We searched the CENTRAL, MEDLINE, Embase, and Science Citation Index until 19 July 2016. We searched the references of included studies to identify further studies. We did not restrict studies based on language or publication status, or whether data were collected prospectively or retrospectively. </p> </section> <section id="CD010213-sec-0004"> <h3 class="title" id="CD010213-sec-0004">Selection criteria</h3> <p>We planned to include studies reporting cross‐sectional information on the index test (CT (computed tomography), MRI (magnetic resonance imaging), PET (positron emission tomography), EUS (endoscopic ultrasound), EUS elastography, and EUS‐guided biopsy or FNA (fine‐needle aspiration)) and reference standard (confirmation of the nature of the lesion was obtained by histopathological examination of the entire lesion by surgical excision, or histopathological examination for confirmation of precancer or cancer by biopsy and clinical follow‐up of at least six months in people with negative index tests) in people with pancreatic lesions irrespective of language or publication status or whether the data were collected prospectively or retrospectively. </p> </section> <section id="CD010213-sec-0005"> <h3 class="title" id="CD010213-sec-0005">Data collection and analysis</h3> <p>Two review authors independently searched the references to identify relevant studies and extracted the data. We planned to use the bivariate analysis to calculate the summary sensitivity and specificity with their 95% confidence intervals and the hierarchical summary receiver operating characteristic (HSROC) to compare the tests and assess heterogeneity, but used simpler models (such as univariate random‐effects model and univariate fixed‐effect model) for combining studies when appropriate because of the sparse data. We were unable to compare the diagnostic performance of the tests using formal statistical methods because of sparse data. </p> </section> <section id="CD010213-sec-0006"> <h3 class="title" id="CD010213-sec-0006">Main results</h3> <p>We included 54 studies involving a total of 3,196 participants evaluating the diagnostic accuracy of various index tests. In these 54 studies, eight different target conditions were identified with different final diagnoses constituting benign, precancerous, and cancerous lesions. None of the studies was of high methodological quality. None of the comparisons in which single studies were included was of sufficiently high methodological quality to warrant highlighting of the results. For differentiation of cancerous lesions from benign or precancerous lesions, we identified only one study per index test. The second analysis, of studies differentiating cancerous versus benign lesions, provided three tests in which meta‐analysis could be performed. The sensitivities and specificities for diagnosing cancer were: EUS‐FNA: sensitivity 0.79 (95% confidence interval (CI) 0.07 to 1.00), specificity 1.00 (95% CI 0.91 to 1.00); EUS: sensitivity 0.95 (95% CI 0.84 to 0.99), specificity 0.53 (95% CI 0.31 to 0.74); PET: sensitivity 0.92 (95% CI 0.80 to 0.97), specificity 0.65 (95% CI 0.39 to 0.84). The third analysis, of studies differentiating precancerous or cancerous lesions from benign lesions, only provided one test (EUS‐FNA) in which meta‐analysis was performed. EUS‐FNA had moderate sensitivity for diagnosing precancerous or cancerous lesions (sensitivity 0.73 (95% CI 0.01 to 1.00) and high specificity 0.94 (95% CI 0.15 to 1.00), the extremely wide confidence intervals reflecting the heterogeneity between the studies). The fourth analysis, of studies differentiating cancerous (invasive carcinoma) from precancerous (dysplasia) provided three tests in which meta‐analysis was performed. The sensitivities and specificities for diagnosing invasive carcinoma were: CT: sensitivity 0.72 (95% CI 0.50 to 0.87), specificity 0.92 (95% CI 0.81 to 0.97); EUS: sensitivity 0.78 (95% CI 0.44 to 0.94), specificity 0.91 (95% CI 0.61 to 0.98); EUS‐FNA: sensitivity 0.66 (95% CI 0.03 to 0.99), specificity 0.92 (95% CI 0.73 to 0.98). The fifth analysis, of studies differentiating cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) provided six tests in which meta‐analysis was performed. The sensitivities and specificities for diagnosing cancer (high‐grade dysplasia or invasive carcinoma) were: CT: sensitivity 0.87 (95% CI 0.00 to 1.00), specificity 0.96 (95% CI 0.00 to 1.00); EUS: sensitivity 0.86 (95% CI 0.74 to 0.92), specificity 0.91 (95% CI 0.83 to 0.96); EUS‐FNA: sensitivity 0.47 (95% CI 0.24 to 0.70), specificity 0.91 (95% CI 0.32 to 1.00); EUS‐FNA carcinoembryonic antigen 200 ng/mL: sensitivity 0.58 (95% CI 0.28 to 0.83), specificity 0.51 (95% CI 0.19 to 0.81); MRI: sensitivity 0.69 (95% CI 0.44 to 0.86), specificity 0.93 (95% CI 0.43 to 1.00); PET: sensitivity 0.90 (95% CI 0.79 to 0.96), specificity 0.94 (95% CI 0.81 to 0.99). The sixth analysis, of studies differentiating cancerous (invasive carcinoma) from precancerous (low‐grade dysplasia) provided no tests in which meta‐analysis was performed. The seventh analysis, of studies differentiating precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) from precancerous (low‐grade dysplasia) provided two tests in which meta‐analysis was performed. The sensitivity and specificity for diagnosing cancer were: CT: sensitivity 0.83 (95% CI 0.68 to 0.92), specificity 0.83 (95% CI 0.64 to 0.93) and MRI: sensitivity 0.80 (95% CI 0.58 to 0.92), specificity 0.81 (95% CI 0.53 to 0.95), respectively. The eighth analysis, of studies differentiating precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) from precancerous (low‐grade dysplasia) or benign lesions provided no test in which meta‐analysis was performed. </p> <p>There were no major alterations in the subgroup analysis of cystic pancreatic focal lesions (42 studies; 2086 participants). None of the included studies evaluated EUS elastography or sequential testing. </p> </section> <section id="CD010213-sec-0007"> <h3 class="title" id="CD010213-sec-0007">Authors' conclusions</h3> <p>We were unable to arrive at any firm conclusions because of the differences in the way that study authors classified focal pancreatic lesions into cancerous, precancerous, and benign lesions; the inclusion of few studies with wide confidence intervals for each comparison; poor methodological quality in the studies; and heterogeneity in the estimates within comparisons. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010213-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010213-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010213-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010213-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010213-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010213-abs-0003" lang="en"> <h3>Accuracy of different imaging techniques for determining whether a pancreatic tumour is cancerous </h3> <p><b>Background</b> </p> <p>The pancreas is an organ in the abdomen that secretes pancreatic juice, which aids digestion and contains cells that produce important hormones such as insulin. Increasingly, abnormalities in the pancreas are noted in people undergoing routine scans, such as ultrasound or computed tomography (CT) scans, in the form of what are known as 'shadows', which may be described as focal pancreatic lesion, pancreatic mass, pancreatic tumour, pancreatic cyst, or pancreatic nodule. A significant proportion of focal pancreatic lesions are benign (non‐cancerous) lesions requiring no treatment. Surgical removal of the tumour is the main method of treatment for precancerous (i.e. focal pancreatic lesions that are not full‐blown cancer and do not have the ability to spread like cancer, but can turn into cancer) and cancerous focal pancreatic lesions. New methods are being developed for treating precancerous lesions, such as using heat to destroy the tumour. Surgical removal remains the only potentially curative treatment for people with limited pancreatic cancer. It is thus important to characterise whether a focal pancreatic lesion is non‐cancerous, precancerous, or cancerous. A number of scans are available for characterising the nature of the focal pancreatic lesion, which include the following. </p> <p>• Computed tomography (CT) scan: a series of X‐rays taken from different angles, which are then reconstructed using a computer. </p> <p>• Magnetic resonance imaging (MRI): the use of a powerful magnet to produce images of different tissues of the body. </p> <p>• Positron emission tomography (PET): the use of a small amount of radioactive glucose (sugar) to differentiate between different tissues. It takes advantage of the tendency of cancer cells to use more glucose than normal cells. </p> <p>• Endoscopic ultrasound (also known as endosonography or EUS): the use of an endoscope, a camera introduced into a body cavity to view the inside of the body. An ultrasound (high‐energy sound waves) probe at the end of the endoscope is used to differentiate tissues. </p> <p>• EUS elastography: this measures the stiffness of the lesion, which is used to identify whether the lesion is cancerous. </p> <p>• EUS‐guided biopsy: the removal of cells or tissues for examination under a microscope or to perform other tests on the cells or tissue. </p> <p>At present it is unclear how effective different scans are in characterising focal pancreatic lesions. </p> <p><b>Study characteristics</b> </p> <p>We performed a thorough literature search for studies reporting the accuracy of different scans until 19 July 2016. We identified 54 studies reporting information on 3196 people with focal pancreatic lesions. These studies evaluated one or more of the above tests and compared these test results with the eventual diagnosis provided by surgical removal of the lesion and examination under microscope. There were no diagnostic test accuracy studies of EUS elastography or studies that looked at multiple scans rather than single scans. </p> <p><b>Key results</b> </p> <p>Variations in how studies defined precancerous and cancerous lesions meant that we were not able to combine the data to provide the overall results for many tests. We were unable to arrive at any firm conclusions for the following reasons. </p> <p>• The way that study authors classified focal pancreatic lesions into cancerous, precancerous, and benign lesions was not consistent in different studies. </p> <p>• The studies included few participants, leading to significant uncertainty in the results. </p> <p>• The studies were of poor methodological quality, which introduced additional uncertainty in the results. </p> <p>• Even among the studies that classified focal pancreatic lesions into cancerous, precancerous, and benign lesions in a similar manner, the results were not consistent. </p> <p><b>Quality of evidence</b> </p> <p>All of the studies were of low methodological quality, which may result in arriving at false conclusions. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010213-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010213-sec-0081"></div> <h3 class="title" id="CD010213-sec-0082">Implications for practice</h3> <section id="CD010213-sec-0082"> <p>We were unable to arrive at any firm conclusions because of the differences in the way that study authors classified focal pancreatic lesions into cancerous, precancerous, and benign lesions; the inclusion of few studies with wide confidence intervals for each comparison; poor methodological quality in the studies; and heterogeneity in the estimates within comparisons. </p> </section> <h3 class="title" id="CD010213-sec-0083">Implications for research</h3> <section id="CD010213-sec-0083"> <p>Further studies of high methodological quality are necessary. Future research should be conducted in a prospective manner, however most importantly the definition of benign and cancerous lesions in the analysis of studies should be standardised according to World Health Organization (WHO) classification. The threshold for positivity of endoscopic ultrasound‐guided fine‐needle aspiration cancer markers should be prespecified. Future studies should avoid any inappropriate exclusions to ensure that true diagnostic accuracy can be determined. Long‐term follow‐up of participants with negative tests will help in understanding the implications of false‐negative results and will aid clinical decision‐making. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010213-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010213-sec-0022"></div> <div class="table" id="CD010213-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Imaging modalities for characterising focal pancreatic lesions</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Name of test</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Number of studies (number of participants)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Sensitivity (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Specificity (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Post‐test probability of positive test* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Post‐test probability of negative test* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Number of false positives per 100 positive index test results (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Number of false negatives per 100 negative index test results (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Risk of bias</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Applicability concerns</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Uncertainty (due to inconsistency or inability to assess inconsistency, and random errors because of overall small sample size)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="11" rowspan="1" valign=""> <p><b> Cancerous versus benign or precancerous (median pre‐test probability: 63%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (45)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.79</b> (0.60 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1.00</b> (0.85 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>98%</b> (79% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>26%</b> (14% to 43%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>2</b> (0 to 21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>26</b> (14 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 500 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (24)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.70 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.33</b> (0.12 to 0.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>70%</b> (59% to 79%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25%</b> (4% to 73%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>30</b> (21 to 41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (4 to 73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (criteria unspecified) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (76)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.85</b> (0.73 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.72 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>94%</b> (81% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21%</b> (12% to 34%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (2 to 19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21</b> (12 to 34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous versus benign (median pre‐test probability: 70%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (133)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.95</b> (0.84 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.53</b> (0.31 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>82%</b> (74% to 88%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18%</b> (6% to 45%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18</b> (12 to 26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18</b> (6 to 45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (147)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.79</b> (0.07 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1.00</b> (0.91 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>99%</b> (90% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32%</b> (2% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32</b> (2 to 92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (criteria unspecified) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.80 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.65</b> (0.39 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>86%</b> (75% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22%</b> (9% to 44%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>14</b> (8 to 25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> (9 to 44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (SUVmax &gt; 3.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.96</b> (0.87 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.62</b> (0.43 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>85%</b> (78% to 90%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12%</b> (3% to 36%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15</b> (10 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12</b> (3 to 36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (123)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.98</b> (0.00 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.76</b> (0.02 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>90%</b> (17% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6%</b> (0% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10</b> (0 to 83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (0 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (29)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.80</b> (0.58 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.89</b> (0.57 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>94%</b> (72% to 99%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>34%</b> (17% to 56%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (1 to 28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>34</b> (17 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Precancerous or cancerous versus benign (median pre‐test probability: 71%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (34)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.74 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.60</b> (0.31 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>85%</b> (72% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25%</b> (7% to 58%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15</b> (8 to 28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (7 to 58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (52)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.73</b> (0.01 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.94</b> (0.15 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>97%</b> (25% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>41%</b> (1% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>3</b> (0 to 75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>41</b> (1 to 98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 50 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (11)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.29</b> (0.08 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.25</b> (0.05 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>48%</b> (20% to 77%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>87%</b> (54% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>52</b> (23 to 80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>87</b> (54 to 98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (SUVmax 2.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (32)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.94</b> (0.74 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.69 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>97%</b> (83% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13%</b> (2% to 49%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>3</b> (0 to 17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13</b> (2 to 49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (48)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.62</b> (0.45 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.64</b> (0.39 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81%</b> (66% to 90%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>59%</b> (44% to 72%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19</b> (10 to 34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>59</b> (44 to 72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (27)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.69 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.85</b> (0.58 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>94%</b> (80% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>17%</b> (3% to 58%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (2 to 20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>17</b> (3 to 58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous (invasive carcinoma) versus precancerous (dysplasia) (median pre‐test probability: 27%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (156)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.78</b> (0.45 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.61 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>75%</b> (37% to 94%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8%</b> (3% to 22%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (6 to 63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8</b> (3 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (158)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.66</b> (0.03 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.73 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>75%</b> (29% to 95%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12%</b> (1% to 69%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (5 to 71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12</b> (1 to 69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (41)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1.00</b> (0.57 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.64</b> (0.48 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>51%</b> (40% to 61%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Not estimable</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>49</b> (39 to 60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Not estimable</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (326)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.72</b> (0.50 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.81 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>78%</b> (57% to 91%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10%</b> (5% to 18%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> (9 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10</b> (5 to 18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (32)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.75</b> (0.30 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.77 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>80%</b> (48% to 94%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>9%</b> (2% to 35%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>20</b> (6 to 52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>9</b> (2 to 35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) (median pre‐test probability: 45%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (196)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.86</b> (0.74 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.83 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>89%</b> (80% to 94%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11%</b> (7% to 19%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (6 to 20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (7 to 19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (310)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.47</b> (0.24 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.32 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81%</b> (19% to 99%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32%</b> (22% to 45%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19</b> (1 to 81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32</b> (22 to 45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (160)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.58</b> (0.28 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.51</b> (0.19 to 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>49%</b> (28% to 70%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>40%</b> (19% to 65%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>51</b> (30 to 72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>40</b> (19 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CA 19‐9 &gt; 1000 U/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (41)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.90</b> (0.60 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.42</b> (0.26 to 0.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>56%</b> (47% to 65%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>16%</b> (3% to 57%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>44</b> (35 to 53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>16</b> (3 to 57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 692.8 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (20)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.80</b> (0.49 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.90</b> (0.60 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>87%</b> (50% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15%</b> (5% to 39%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13</b> (2 to 50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15</b> (5 to 39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (SUVmax &gt; 2 to 2.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (124)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.90</b> (0.79 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.94</b> (0.81 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>93%</b> (78% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8%</b> (4% to 16%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>7</b> (2 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8</b> (4 to 16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (139)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.87</b> (0.00 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.96</b> (0.00 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95%</b> (0% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10%</b> (0% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5</b> (0 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10</b> (0 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (189)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.69</b> (0.44 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.43 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>89%</b> (35% to 99%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21%</b> (12% to 36%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (1 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21</b> (12 to 36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) (median pre‐test probability: 21%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (51)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.77</b> (0.50 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.89</b> (0.76 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>67%</b> (43% to 84%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>7%</b> (3% to 16%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>33</b> (16 to 57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>7</b> (3 to 16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (46)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.50</b> (0.22 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.95</b> (0.83 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>72%</b> (36% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13%</b> (7% to 22%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>28</b> (8 to 64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13</b> (7 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) (median pre‐test probability: 59%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (106)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.83</b> (0.68 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.83</b> (0.64 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>89%</b> (56% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>33%</b> (18% to 52%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (2 to 44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>33</b> (18 to 52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (71)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.80</b> (0.58 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.81</b> (0.53 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>86%</b> (67% to 95%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>27%</b> (13% to 47%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>14</b> (5 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>27</b> (13 to 47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign (median pre‐test probability: 43%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (70)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.97</b> (0.83 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.40</b> (0.26 to 0.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>55%</b> (48% to 61%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6%</b> (1% to 31%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>45</b> (39 to 52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (1 to 31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>*Post‐test probability was calculated at the median pre‐test probability.</p> <p>Abbreviations:</p> <p>CA 19‐9: carbohydrate antigen 19‐9<br/> CEA: carcinoembryonic antigen<br/> CI: confidence interval<br/> CT: computed tomography<br/> EUS: endoscopic ultrasound<br/> FNA: fine‐needle aspiration<br/> MRI: magnetic resonance imaging<br/> PET: positron emission tomography<br/> SUVmax: maximum standardised uptake values </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010213-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010213-sec-0023"></div> <p>(Please see the glossary in <a href="./appendices#CD010213-sec-0087">Appendix 1</a> for terms that have not been described in the main text.) </p> <p>A 'shadow’ identified in the pancreas on imaging may be variously described as a focal pancreatic lesion, pancreatic mass, pancreatic tumour, pancreatic cyst, or pancreatic nodule. This phrasing refers to focal lesions, as opposed to diffuse changes of the pancreas, and includes solid and cystic lesions of the pancreas. In the Western world, the prevalence of focal pancreatic lesions is approximately 1.2% and is increasing steadily (by approximately 8%) each year, with smaller and asymptomatic lesions being identified more frequently (<a href="./references#CD010213-bbs2-0940" title="GaujouxS , BrennanMF , GonenM , D'AngelicaMI , DematteoR , FongY , et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15‐year time period. Journal of the American College of Surgeons2011;212(4):590‐600. ">Gaujoux 2011</a>; <a href="./references#CD010213-bbs2-0976" title="SpinelliKS , FromwillerTE , DanielRA , KielyJM , NakeebA , KomorowskiRA , et al. Cystic pancreatic neoplasms: observe or operate. Annals of Surgery2004;239(5):651‐7. ">Spinelli 2004</a>). An incidental pancreatic lesion is one that is detected in the pancreas of a patient who undergoes radiological investigations for an unrelated medical condition (<a href="./references#CD010213-bbs2-0972" title="SachsT , PrattWB , CalleryMP , VollmerCMJr . The incidental asymptomatic pancreatic lesion: nuisance or threat?. Journal of Gastrointestinal Surgery2009;13(3):405‐15. ">Sachs 2009</a>). Such asymptomatic incidental lesions represent 55% to 60% of pancreatic tumours (<a href="./references#CD010213-bbs2-0940" title="GaujouxS , BrennanMF , GonenM , D'AngelicaMI , DematteoR , FongY , et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15‐year time period. Journal of the American College of Surgeons2011;212(4):590‐600. ">Gaujoux 2011</a>; <a href="./references#CD010213-bbs2-0976" title="SpinelliKS , FromwillerTE , DanielRA , KielyJM , NakeebA , KomorowskiRA , et al. Cystic pancreatic neoplasms: observe or operate. Annals of Surgery2004;239(5):651‐7. ">Spinelli 2004</a>). Some focal pancreatic lesions may be associated with symptoms, depending upon their size and nature. The symptoms of pancreatic cancer, which generally refers to pancreatic adenocarcinoma, can include obstructive jaundice (yellowish discolouration of the skin and the whites of the eyes with dark urine and pale stool due to blockage of bile duct (<a href="./references#CD010213-bbs2-0962" title="National Cancer Institute (U.S. National Institutes of Health). Dictionary of cancer terms. CT scan. www.cancer.gov/dictionary?CdrID=46033 (accessed 25 September 2012). ">National Cancer Institute 2011a</a>), a tube that transports the bile from the liver), loss of appetite, and abdominal pain (<a href="./references#CD010213-bbs2-0948" title="HollyEA , ChalihaI , BracciPM , GautamM . Signs and symptoms of pancreatic cancer: a population‐based case‐control study in the San Francisco Bay Area. Clinical Gastroenterology and Hepatology2004;2(6):510‐7. ">Holly 2004</a>). The symptoms of pancreatic neuroendocrine tumours (tumours arising from cells that secrete hormones), some of which may be cancer, are related to the excessive secretion of hormones (by the tumour) such as insulin, glucagon, gastrin, somatostatin, and vasoactive peptide resulting in hypoglycaemia (decreased blood sugar), hyperglycaemia (increased blood sugar, a rare cause of diabetes), and gastrointestinal disturbances such as peptic ulcer and diarrhoea (<a href="./references#CD010213-bbs2-0927" title="BatcherE , MadajP , GianoukakisAG . Pancreatic neuroendocrine tumors. Endocrine Research2011;36(1):35‐43. ">Batcher 2011</a>). The symptoms of chronic pancreatitis (chronic inflammation of the pancreas that can result in alteration in the structure and function of the pancreas) are abdominal and back pain and those symptoms related to pancreatic insufficiency, which include steatorrhoea, malabsorption, vitamin deficiency, diabetes, or weight loss (<a href="./references#CD010213-bbs2-0929" title="BraganzaJM , LeeSH , McCloyRF , McMahonMJ . Chronic pancreatitis. Lancet2011;377(9772):1184‐97. ">Braganza 2011</a>; <a href="./references#CD010213-bbs2-0960" title="NairRJ , LawlerL , MillerMR . Chronic pancreatitis. American Family Physician2007;76(11):1679‐88. ">Nair 2007</a>). About 40% of people with focal pancreatic lesions have chronic pancreatitis (<a href="./references#CD010213-bbs2-0976" title="SpinelliKS , FromwillerTE , DanielRA , KielyJM , NakeebA , KomorowskiRA , et al. Cystic pancreatic neoplasms: observe or operate. Annals of Surgery2004;239(5):651‐7. ">Spinelli 2004</a>). In the remaining 60% of people with focal pancreatic lesions, the remaining pancreas is normal. </p> <p>Focal pancreatic lesions can be benign (serous pancreatic cystadenoma, acinar cell cystadenoma, papillary cysts, lymphoepithelial cysts, simple cysts), precancerous (intraductal papillary mucinous neoplasm (IPMN) with dysplasia but without invasive cancer, mucinous cystic neoplasm (MCN), benign neuroendocrine tumours), or cancer (ductal adenocarcinoma, acinar cell carcinoma, IPMN with invasive carcinoma, cystadenocarcinoma, pancreatoblastoma, solid pseudo‐papillary neoplasm, cancer neuroendocrine tumours) (<a href="./references#CD010213-bbs2-0955" title="LuttgesJ . What's new? The 2010 WHO classification for tumours of the pancreas. Pathologe2011;32 Suppl 2:332‐6. ">Luttges 2011</a>; <a href="./references#CD010213-bbs2-0972" title="SachsT , PrattWB , CalleryMP , VollmerCMJr . The incidental asymptomatic pancreatic lesion: nuisance or threat?. Journal of Gastrointestinal Surgery2009;13(3):405‐15. ">Sachs 2009</a>; <a href="./references#CD010213-bbs2-0976" title="SpinelliKS , FromwillerTE , DanielRA , KielyJM , NakeebA , KomorowskiRA , et al. Cystic pancreatic neoplasms: observe or operate. Annals of Surgery2004;239(5):651‐7. ">Spinelli 2004</a>; <a href="./references#CD010213-bbs2-0983" title="World Health Organization. WHO Classification of Tumours of the Digestive System: C25 ‐ Pancreas. www.pubcan.org/searchresults.php?topo=c25&amp;action=search (accessed 8 April 2016). ">WHO 2016</a>). Dysplasia can be low grade, intermediate grade, or high grade (<a href="./references#CD010213-bbs2-0983" title="World Health Organization. WHO Classification of Tumours of the Digestive System: C25 ‐ Pancreas. www.pubcan.org/searchresults.php?topo=c25&amp;action=search (accessed 8 April 2016). ">WHO 2016</a>). About 80% of benign lesions, 50% of precancerous lesions, and 20% of cancerous lesions are asymptomatic (<a href="./references#CD010213-bbs2-0976" title="SpinelliKS , FromwillerTE , DanielRA , KielyJM , NakeebA , KomorowskiRA , et al. Cystic pancreatic neoplasms: observe or operate. Annals of Surgery2004;239(5):651‐7. ">Spinelli 2004</a>). Focal pancreatic lesions can be solid or cystic or mixed solid and cystic tumours (<a href="./references#CD010213-bbs2-0931" title="ChoHW , ChoiJY , KimMJ , ParkMS , LimJS , ChungYE , et al. Pancreatic tumors: emphasis on CT findings and pathologic classification. Korean Journal of Radiology2011;12(6):731‐9. ">Cho 2011</a>). </p> <p>Surgical resection is generally considered to be the only curative treatment for pancreatic cancer. Worldwide, only 15% to 20% of people with pancreatic cancer undergo potentially curative resection (<a href="./references#CD010213-bbs2-0933" title="ConlonKC , KlimstraDS , BrennanMF . Long‐term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5‐year survivors. Annals of Surgery1996;223(3):273‐9. ">Conlon 1996</a>; <a href="./references#CD010213-bbs2-0937" title="EngelkenFJ , BettschartV , RahmanMQ , ParksRW , GardenOJ . Prognostic factors in the palliation of pancreatic cancer. European Journal of Surgical Oncology2003;29(4):368‐73. ">Engelken 2003</a>; <a href="./references#CD010213-bbs2-0951" title="KatzMH , WangH , FlemingJB , SunCC , HwangRF , WolffRA , et al. Long‐term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Annals of Surgical Oncology2009;16(4):836‐47. ">Katz 2009</a>; <a href="./references#CD010213-bbs2-0959" title="MichelassiF , ErroiF , DawsonPJ , PietrabissaA , NodaS , HandcockM , et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Annals of Surgery1989;210(4):544‐54. ">Michelassi 1989</a>; <a href="./references#CD010213-bbs2-0974" title="ShahrudinMD . Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur. International Surgery1997;82(3):269‐74. ">Shahrudin 1997</a>; <a href="./references#CD010213-bbs2-0975" title="SmithRA , BosonnetL , GhanehP , SuttonR , EvansJ , HealeyP , et al. The platelet‐lymphocyte ratio improves the predictive value of serum CA19‐9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery2008;143(5):658‐66. ">Smith 2008</a>). In the remaining patients, the cancers are not resected because of infiltration of local structures or disseminated disease. Early diagnosis of pancreatic cancer might enable resection of the pancreatic cancer before it is too late to resect. Pancreatic resection is a major surgery, with an approximately 1% to 25% risk of perioperative death reported worldwide (<a href="./references#CD010213-bbs2-0933" title="ConlonKC , KlimstraDS , BrennanMF . Long‐term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5‐year survivors. Annals of Surgery1996;223(3):273‐9. ">Conlon 1996</a>; <a href="./references#CD010213-bbs2-0951" title="KatzMH , WangH , FlemingJB , SunCC , HwangRF , WolffRA , et al. Long‐term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Annals of Surgical Oncology2009;16(4):836‐47. ">Katz 2009</a>; <a href="./references#CD010213-bbs2-0959" title="MichelassiF , ErroiF , DawsonPJ , PietrabissaA , NodaS , HandcockM , et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Annals of Surgery1989;210(4):544‐54. ">Michelassi 1989</a>; <a href="./references#CD010213-bbs2-0974" title="ShahrudinMD . Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur. International Surgery1997;82(3):269‐74. ">Shahrudin 1997</a>; <a href="./references#CD010213-bbs2-0980" title="vanOostFJ , LuitenEJ , van dePoll‐FranseLV , CoeberghJW , van denEijnden‐van RaaijAJ . Outcome of surgical treatment of pancreatic, peri‐ampullary and ampullary cancer diagnosed in the south of the Netherlands: a cancer registry based study. European Journal of Surgical Oncology2006;32(5):548‐52. ">van Oost 2006</a>). High‐volume centres show a lower perioperative mortality of less than 5% compared to low‐volume centres, which are associated with a perioperative mortality of up to 25% (<a href="./references#CD010213-bbs2-0944" title="GurusamyKS , KotiR , FusaiG , DavidsonBR . Somatostatin analogues for pancreatic surgery. Cochrane Database of Systematic Reviews2013, Issue 4. [DOI: 10.1002/14651858.CD008370.pub3] ">Gurusamy 2013</a>; <a href="./references#CD010213-bbs2-0980" title="vanOostFJ , LuitenEJ , van dePoll‐FranseLV , CoeberghJW , van denEijnden‐van RaaijAJ . Outcome of surgical treatment of pancreatic, peri‐ampullary and ampullary cancer diagnosed in the south of the Netherlands: a cancer registry based study. European Journal of Surgical Oncology2006;32(5):548‐52. ">van Oost 2006</a>). Pancreatic resection is also associated with an about 40% morbidity rate (<a href="./references#CD010213-bbs2-0944" title="GurusamyKS , KotiR , FusaiG , DavidsonBR . Somatostatin analogues for pancreatic surgery. Cochrane Database of Systematic Reviews2013, Issue 4. [DOI: 10.1002/14651858.CD008370.pub3] ">Gurusamy 2013</a>; <a href="./references#CD010213-bbs2-0979" title="van derGaagNA , RauwsEA , vanEijckCH , BrunoMJ , van derHarstE , KubbenFJ , et al. Preoperative biliary drainage for cancer of the head of the pancreas. New England Journal of Medicine2010;362(2):129‐37. ">van der Gaag 2010</a>). Only 5% to 25% of patients survive for five years (<a href="./references#CD010213-bbs2-0933" title="ConlonKC , KlimstraDS , BrennanMF . Long‐term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5‐year survivors. Annals of Surgery1996;223(3):273‐9. ">Conlon 1996</a>; <a href="./references#CD010213-bbs2-0951" title="KatzMH , WangH , FlemingJB , SunCC , HwangRF , WolffRA , et al. Long‐term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Annals of Surgical Oncology2009;16(4):836‐47. ">Katz 2009</a>; <a href="./references#CD010213-bbs2-0959" title="MichelassiF , ErroiF , DawsonPJ , PietrabissaA , NodaS , HandcockM , et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Annals of Surgery1989;210(4):544‐54. ">Michelassi 1989</a>; <a href="./references#CD010213-bbs2-0974" title="ShahrudinMD . Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur. International Surgery1997;82(3):269‐74. ">Shahrudin 1997</a>). Surgery is generally offered if there are features suggestive of precancerous or cancerous lesions (<a href="./references#CD010213-bbs2-0953" title="LeeSY , LeeKT , LeeJK , JeonYH , ChoiD , LimJH , et al. Long‐term follow up results of intraductal papillary mucinous tumors of pancreas. Journal of Gastroenterology and Hepatology2005;20(9):1379‐84. ">Lee 2005c</a>), although some clinicians prefer sequential follow‐up (by imaging) of precancerous lesions to surgical resection (<a href="./references#CD010213-bbs2-0950" title="IrieH , YoshimitsuK , AibeH , TajimaT , NishieA , NakayamaT , et al. Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow‐up study by magnetic resonance cholangiopancreatography. Journal of Computer Assisted Tomography2004;28(1):117‐22. [14716244] ">Irie 2004</a>). Surgery is offered when there is an increase in the size or morphology (the way the lesion appears) of the lesion in sequential imaging (<a href="./references#CD010213-bbs2-0940" title="GaujouxS , BrennanMF , GonenM , D'AngelicaMI , DematteoR , FongY , et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15‐year time period. Journal of the American College of Surgeons2011;212(4):590‐600. ">Gaujoux 2011</a>). Surgery is also offered when there is considerable uncertainty as to the nature of the lesion. In some ways, surgery can be considered as a diagnostic test for characterisation of the lesion and as a treatment for people with cancerous and precancerous lesions. Histological confirmation of the lesion by percutaneous biopsy is generally not performed because of difficulty in accessing the lesion percutaneously and because of dissemination of cancer cells. </p> <section id="CD010213-sec-0024"> <h3 class="title" id="CD010213-sec-0024">Target condition being diagnosed</h3> <p> <ol id="CD010213-list-0001"> <li> <p>Cancerous versus benign or precancerous lesions.</p> </li> <li> <p>Precancerous or cancerous (including the type of cancerous lesion) versus benign lesions.</p> </li> </ol> </p> </section> <section id="CD010213-sec-0025"> <h3 class="title" id="CD010213-sec-0025">Index test(s)</h3> <section id="CD010213-sec-0026"> <h4 class="title">Computed tomography (CT) scan</h4> <p>This involves a series of X‐rays taken from different angles, which are then reconstructed using a computer (<a href="./references#CD010213-bbs2-0962" title="National Cancer Institute (U.S. National Institutes of Health). Dictionary of cancer terms. CT scan. www.cancer.gov/dictionary?CdrID=46033 (accessed 25 September 2012). ">National Cancer Institute 2011a</a>). Morphological features of the lesion, such as density, regularity of margins, vascularity, and the diameter of the pancreatic duct, are taken into account to characterise the lesion. The main side effect of CT scan is the ionising radiation (radioactivity) associated with it. Everyone is exposed to very small amounts of radiation (background radiation). One CT scan of the abdomen is equivalent to approximately three years of background radiation (<a href="./references#CD010213-bbs2-0938" title="FredHL . Drawbacks and limitations of computed tomography: views from a medical educator. Texas Heart Institute Journal2004; Vol. 31, issue 4:345‐8. ">Fred 2004</a>). In addition, the contrast material (dye used to view the structures better) can cause allergic reactions, such as difficulty breathing, or kidney damage, particularly in people with pre‐existing kidney disease (<a href="./references#CD010213-bbs2-0961" title="NamasivayamS , KalraMK , TorresWE , SmallWC . Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emergency Radiology2006;12(5):210‐5. ">Namasivayam 2006</a>). </p> </section> <section id="CD010213-sec-0027"> <h4 class="title">Magnetic resonance imaging (MRI)</h4> <p>This involves the use of a powerful magnet to produce images of different tissues of the body. Magnetic resonance imaging is also known as nuclear magnetic resonance imaging (NMRI) (<a href="./references#CD010213-bbs2-0963" title="National Cancer Institute (U.S. National Institutes of Health). Dictionary of cancer terms. Magnetic resonance imaging. www.cancer.gov/dictionary?CdrID=45997 (accessed 25 September 2012). ">National Cancer Institute 2011b</a>). Similar features as those employed in CT scan are used to characterise the lesion. While MRI does not use radiation, it is contraindicated in people with metallic implants such as artificial joints, those with cardiac pacemakers (devices used to control heart rhythm), and those with claustrophobia (fear of closed spaces) (<a href="./references#CD010213-bbs2-0935" title="DillT . Contraindications to magnetic resonance imaging: non‐invasive imaging. Heart2008;94(7):943‐8. ">Dill 2008</a>). Some of the contrasts used can also cause kidney damage (<a href="./references#CD010213-bbs2-0935" title="DillT . Contraindications to magnetic resonance imaging: non‐invasive imaging. Heart2008;94(7):943‐8. ">Dill 2008</a>). </p> </section> <section id="CD010213-sec-0028"> <h4 class="title">Positron emission tomography (PET)</h4> <p>This involves the use of a small amount of radioactive glucose (sugar) to differentiate between different tissues. It takes advantage of the tendency of cancer cells to use more glucose than normal cells. Positron emission tomography is also known as PET scan (<a href="./references#CD010213-bbs2-0964" title="National Cancer Institute (U.S. National Institutes of Health). Dictionary of cancer terms. Positron emission tomography. www.cancer.gov/dictionary?CdrID=46218 (accessed 25 September 2012). ">National Cancer Institute 2011c</a>). Cancerous lesions appear as areas of increased uptake. Positron emission tomography also uses ionising radiation (<a href="./references#CD010213-bbs2-0954" title="Leide‐SvegbornS . Radiation exposure of patients and personnel from a PET/CT procedure with 18F‐FDG. Radiation Protection Dosimetry2010;139(1‐3):208‐13. ">Leide‐Svegborn 2010</a>). The radiation exposure to one PET scan is similar to that in one CT scan of abdomen (<a href="./references#CD010213-bbs2-0938" title="FredHL . Drawbacks and limitations of computed tomography: views from a medical educator. Texas Heart Institute Journal2004; Vol. 31, issue 4:345‐8. ">Fred 2004</a>; <a href="./references#CD010213-bbs2-0954" title="Leide‐SvegbornS . Radiation exposure of patients and personnel from a PET/CT procedure with 18F‐FDG. Radiation Protection Dosimetry2010;139(1‐3):208‐13. ">Leide‐Svegborn 2010</a>). </p> </section> <section id="CD010213-sec-0029"> <h4 class="title">Endoscopic ultrasound (EUS)</h4> <p>This involves the use of an endoscope, a camera introduced into a body cavity to view the inside of the body. An ultrasound (high‐energy sound waves) probe at the end of the endoscope is used to differentiate tissues. Endoscopic ultrasound is also known as endosonography (<a href="./references#CD010213-bbs2-0965" title="National Cancer Institute (U.S. National Institutes of Health). Dictionary of cancer terms. Endoscopic ultrasound. www.cancer.gov/dictionary?CdrID=46602 (accessed 25 September 2012). ">National Cancer Institute 2011d</a>). Features such as echogenicity and regularity of margins are taken into account and used to characterise the lesion. Complications following EUS are rare and include perforation (<a href="./references#CD010213-bbs2-0928" title="BensonME , ByrneS , BrustDJ , ManningB3rd , PfauPR , FrickTJ , et al. EUS and ERCP complication rates are not increased in elderly patients. Digestive Diseases and Sciences2010;55(11):3278‐83. ">Benson 2010</a>; <a href="./references#CD010213-bbs2-0968" title="NivY , GershtanskyY , KenettRS , TalY , BirkenfeldS . Complications in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS): analysis of 7‐year physician‐reported adverse events. Drug, Healthcare and Patient Safety2011;3:21‐5. ">Niv 2011</a>). </p> </section> <section id="CD010213-sec-0030"> <h4 class="title">EUS elastography</h4> <p>This measures the stiffness of the lesion, which can be used to identify whether the lesion is benign or cancerous (<a href="./references#CD010213-bbs2-0365" title="Iglesias‐GarciaJ , Larino‐NoiaJ , AbdulkaderI , FortezaJ , Dominguez‐MunozJE . Quantitative endoscopic ultrasound elastography: An accurate method for the differentiation of solid pancreatic masses. Gastroenterology2010;139(4):1172‐80. ">Iglesias‐Garcia 2010</a>). The complications associated with EUS elastography are the same as with EUS. </p> </section> <section id="CD010213-sec-0031"> <h4 class="title">EUS‐guided biopsy</h4> <p>This is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: </p> <p> <ol id="CD010213-list-0002"> <li> <p>incisional biopsy, in which only a sample of tissue is removed;</p> </li> <li> <p>excisional biopsy, in which an entire lump or suspicious area is removed; and</p> </li> <li> <p>needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used the procedure is called a core biopsy. When a thin needle is used the procedure is called a fine‐needle aspiration biopsy (FNAB) (<a href="./references#CD010213-bbs2-0966" title="National Cancer Institute (U.S. National Institutes of Health). Dictionary of cancer terms. Biopsy. www.cancer.gov/dictionary?CdrID=335081 (accessed 25 September 2012). ">National Cancer Institute 2011e</a>). </p> </li> </ol> </p> <p>Because of the risk of dissemination from cancer, EUS‐guided biopsy is preferable to percutaneous (image‐guided) biopsy (<a href="./references#CD010213-bbs2-0958" title="MicamesC , JowellPS , WhiteR , PaulsonE , NelsonR , MorseM , et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS‐guided FNA vs. percutaneous FNA. Gastrointestinal Endoscopy2003;58(5):690‐5. ">Micames 2003</a>). The examinations under the microscope used may include the routine haemotoxylin and eosin stain for core biopsy and special staining for FNAB (<a href="./references#CD010213-bbs2-0956" title="MehtaN , ModiL , PatelT , ShahM . Study of cytomorphology of solid pseudopapillary tumor of pancreas and its differential diagnosis. Journal of Cytology2010;27(4):118‐22. ">Mehta 2010</a>). Immunocytochemistry and proteomic profiling to identify the presence of biomarkers in the tissue may also be used in the diagnosis (<a href="./references#CD010213-bbs2-0934" title="CuiY , TianM , ZongM , TengM , ChenY , LuJ , et al. Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma. Pancreatology2009;9(1‐2):89‐98. ">Cui 2009</a>; <a href="./references#CD010213-bbs2-0956" title="MehtaN , ModiL , PatelT , ShahM . Study of cytomorphology of solid pseudopapillary tumor of pancreas and its differential diagnosis. Journal of Cytology2010;27(4):118‐22. ">Mehta 2010</a>). A positive core biopsy can confirm cancer, but a negative core biopsy cannot rule out cancer. Cytology results are not quite as reliable as core biopsy as false‐positive cytology has been reported (<a href="./references#CD010213-bbs2-0945" title="HanckeS , HolmHH , KochF . Ultrasonically guided puncture of solid pancreatic mass lesions. Ultrasound in Medicine and Biology1984;10(5):613‐5. ">Hancke 1984</a>). </p> <p>Complications associated with EUS‐guided biopsy include those associated with EUS as well as bleeding (<a href="./references#CD010213-bbs2-0928" title="BensonME , ByrneS , BrustDJ , ManningB3rd , PfauPR , FrickTJ , et al. EUS and ERCP complication rates are not increased in elderly patients. Digestive Diseases and Sciences2010;55(11):3278‐83. ">Benson 2010</a>; <a href="./references#CD010213-bbs2-0968" title="NivY , GershtanskyY , KenettRS , TalY , BirkenfeldS . Complications in endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS): analysis of 7‐year physician‐reported adverse events. Drug, Healthcare and Patient Safety2011;3:21‐5. ">Niv 2011</a>). </p> <p>Of these index tests, the commonly available tests are CT scan and MRI. The remaining tests (PET, EUS, EUS elastography, and EUS‐guided biopsy) are available in major tertiary centres only. </p> </section> </section> <section id="CD010213-sec-0032"> <h3 class="title" id="CD010213-sec-0032">Clinical pathway</h3> <p>There is no standard algorithm in the diagnosis or management of focal pancreatic lesions. The algorithm may vary from one centre to another and even within the same centre (<a href="./references#CD010213-bbs2-0940" title="GaujouxS , BrennanMF , GonenM , D'AngelicaMI , DematteoR , FongY , et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15‐year time period. Journal of the American College of Surgeons2011;212(4):590‐600. ">Gaujoux 2011</a>; <a href="./references#CD010213-bbs2-0943" title="GohBK , TanYM , CheowPC , ChungYF , ChowPK , WongWK , et al. Cystic lesions of the pancreas: an appraisal of an aggressive resectional policy adopted at a single institution during 15 years. American Journal of Surgery2006;192(2):148‐54. ">Goh 2006b</a>). One possible diagnostic clinical pathway is shown in <a href="#CD010213-fig-0001">Figure 1</a>. As noted in <a href="#CD010213-fig-0001">Figure 1</a>, an increase in the size of or change of morphological features is one of the reasons that surgeons recommend surgical excision, as this may indicate that the lesion was malignant in the first instance (without features suggestive of malignancy in the original scan) or has transformed into a malignant lesion. The interval for sequential scans is variable. Our local protocol advises sequential scanning in one year in the absence of malignant features. It is important to distinguish whether the focal pancreatic lesion is benign with no cancer potential so that unnecessary surgery and anxiety can be avoided. It is also important to know whether the lesion is precancerous or cancerous so that an informed decision about surgery can be made after weighing the potential benefits and harms. In addition, new alternative treatments such as radiofrequency ablation (destruction of tissue using radiofrequency waves) are being evaluated for precancerous lesions (<a href="./references#CD010213-bbs2-0969" title="PereiraSP . A phase II multicentre trial of endoscopic ultrasound guided radiofrequency ablation of cystic tumours of the pancreas (RADIOCYST01). clinicaltrials.gov/ct2/show/NCT02343692 (first received 12 January 2015). ">Pereira 2015</a>). It is also necessary to differentiate the different types of cancer, since different malignancies carry different prognoses (<a href="./references#CD010213-bbs2-0952" title="KlempnauerJ , RidderGJ , PichlmayrR . Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head. British Journal of Surgery1995;82(12):1686‐91. ">Klempnauer 1995</a>). Some surgeons follow the single‐test strategy, that is making decisions based on the features of the lesion in a single test, while others follow repeated testing (repeating the imaging modality or using a different imaging modality), particularly if the nature of the lesion is indeterminate. The optimal interval between the tests in the repeated‐testing strategy is unknown. </p> <div class="figure" id="CD010213-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Clinical pathway.Abbreviations:Ca 19‐9: carbohydrate antigen 19‐9  CT: computed tomography  EUS: endoscopic ultrasound  MRI: magnetic resonance imaging  PET: positron emission tomography" data-id="CD010213-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Clinical pathway.</p> <p>Abbreviations:</p> <p>Ca 19‐9: carbohydrate antigen 19‐9<br/> CT: computed tomography<br/> EUS: endoscopic ultrasound<br/> MRI: magnetic resonance imaging<br/> PET: positron emission tomography </p> </div> </div> </div> <section id="CD010213-sec-0033"> <h4 class="title">Prior test(s)</h4> <p>The tests that occur prior to pancreatic imaging depend on how the patient presents. The investigation may be targeted if the patient presents with abdominal symptoms, however it is equally possible that the pancreatic lesion is an incidental finding on an abdominal scan for an alternative reason. As pancreatic cancer is relatively late presenting (<a href="./references#CD010213-bbs2-0970" title="PortaM , FabregatX , MalatsN , GuarnerL , CarratoA , deMiguelA , et al. Exocrine pancreatic cancer: Symptoms at presentation and their relation to tumour site and stage. Clinical and Translational Oncology2005;7(5):189‐97. ">Porta 2005</a>), the number of incidental lesions found will be high comparative to other cancers where symptoms will primarily drive discovery. Whilst CT, MRI, and PET may identify incidental lesions, EUS and EUS‐guided fine‐needle aspiration (EUS‐FNA) are the likely second test for known lesions of symptomatic individuals. </p> </section> <section id="CD010213-sec-0034"> <h4 class="title">Role of index test(s)</h4> <p>All of the index tests described are used primarily to characterise pancreatic lesions as either benign or cancerous, or more importantly as needing significant or more conservative treatment. The location of the pancreas makes percutaneous biopsy dangerous because of the risk of cancer spread, therefore determination of cancer stage and consequently required treatment must be made non‐invasively by the imaging techniques and by EUS‐FNA. </p> </section> <section id="CD010213-sec-0035"> <h4 class="title">Alternative test(s)</h4> <p>Computed tomography is usually part of a standard algorithm for assessing focal pancreatic lesions (<a href="./references#CD010213-bbs2-0940" title="GaujouxS , BrennanMF , GonenM , D'AngelicaMI , DematteoR , FongY , et al. Cystic lesions of the pancreas: changes in the presentation and management of 1,424 patients at a single institution over a 15‐year time period. Journal of the American College of Surgeons2011;212(4):590‐600. ">Gaujoux 2011</a>). If the incidental lesion is detected on CT scan, then CT scan can be the only investigation, since the added value of the other tests is not known. One or more of the above tests may be used in addition to, or instead of, CT scan. Diagnostic laparoscopy and laparoscopic ultrasound are other tests that may be used in the differential diagnosis of focal pancreatic lesions; however, these tests are not used routinely. Serum carbohydrate antigen 19‐9 (CA 19‐9) is a substance released into the bloodstream by both cancer cells and normal cells and is used as a type of tumour marker (<a href="./references#CD010213-bbs2-0967" title="National Cancer Institute (U.S. National Institutes of Health). Dictionary of cancer terms. CA 19‐9. www.cancer.gov/dictionary?CdrID=633729 (accessed 25 September 2012). ">National Cancer Institute 2011f</a>). Excessive CA 19‐9 in the blood can be a sign of pancreatic cancer or other types of cancer or conditions. The amount of CA 19‐9 in the blood can be used to measure how effective cancer treatments are or if cancer has returned. It can be used in conjunction with other imaging modalities in the assessment of the focal pancreatic lesion. </p> </section> </section> <section id="CD010213-sec-0036"> <h3 class="title" id="CD010213-sec-0036">Rationale</h3> <p>The various imaging modalities use different methods to differentiate normal and diseased tissues. Endoscopic ultrasound is closer to the tissues and therefore high‐frequency ultrasound waves can be used, which have better resolution but poorer penetration than an external ultrasound. Image‐guided biopsy can be performed and the tissue can be examined under the microscope to differentiate between types of focal pancreatic lesion. </p> <p>Accurate characterisation of lesions will help in patient management. Patients with cancerous lesions will be offered surgery if there is no distant spread of cancer and assuming they are fit for major surgery. Patients with cancerous lesions who are not eligible for surgery because of distant spread of cancer or lack of fitness for major surgery will be offered other treatments such as chemotherapy. Patients with precancerous lesions may also undergo surgery or ablation depending upon the clinician and patient preferences. Unnecessary major surgery can be avoided in patients with benign lesions. </p> <p>There is currently no Cochrane review of studies assessing the diagnostic accuracy of different imaging modalities in the assessment of focal pancreatic lesions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010213-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010213-sec-0037"></div> <p>To determine and compare the diagnostic accuracy of various imaging modalities in detecting cancerous and precancerous lesions in people with focal pancreatic lesions. </p> <section id="CD010213-sec-0038"> <h3 class="title" id="CD010213-sec-0038">Secondary objectives</h3> <p>We planned to explore the following sources of heterogeneity.</p> <p> <ol id="CD010213-list-0003"> <li> <p>Studies at low risk of bias versus those at unclear or high risk of bias (as assessed by the revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool as recommended by the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/CE000068/sect0-meta.html" target="_blank">Cochrane Screening and Diagnostic Tests Methods Group</a>) (<a href="./references#CD010213-bbs2-0981" title="WhitingPF , WeswoodME , RutjesAW , ReitsmaJB , BossuytPN , KleijnenJ . Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Medical Research Methodology2006;6:9. ">Whiting 2006</a>). In particular, we considered the studies classified as 'yes' for the items differential verification, un‐interpretable results, and withdrawals as the most important sources of heterogeneity. </p> </li> <li> <p>Full‐text publications versus abstracts (this might be indicative of publication bias, since there may be an association between the results of the study and the study reaching full publication) (<a href="./references#CD010213-bbs2-0936" title="EloubeidiMA , WadeSB , ProvenzaleD . Factors associated with acceptance and full publication of GI endoscopic research originally published in abstract form. Gastrointestinal Endoscopy2001;53(3):275‐82. ">Eloubeidi 2001</a>). </p> </li> <li> <p>Prospective studies versus retrospective studies.</p> </li> <li> <p>Different types of reference standard.</p> </li> <li> <p>Symptomatic versus asymptomatic lesions (the presence of symptoms may increase the pre‐test probability). </p> </li> <li> <p>Solid versus cystic lesions (as the diagnostic accuracy of the imaging modalities may vary depending upon whether the lesion is solid or cystic). </p> </li> <li> <p>Participants with chronic pancreatitis versus those without chronic pancreatitis.</p> </li> <li> <p>Different criteria used by the authors to classify the lesions.</p> </li> <li> <p>Single imaging versus sequential imaging (repeated imaging).</p> </li> <li> <p>Different intervals of sequential imaging (e.g. imaging every six months versus annual review). </p> </li> </ol> </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010213-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010213-sec-0039"></div> <section id="CD010213-sec-0040"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010213-sec-0041"> <h4 class="title">Types of studies</h4> <p>We included studies reporting on cross‐sectional information of the index test and reference test in the appropriate patient population (see below), irrespective of language or publication status or whether the data were collected prospectively or retrospectively. However, we excluded case series in which only true‐positive results or true‐negative results were reported without any information on the other participants who underwent the test. </p> </section> <section id="CD010213-sec-0042"> <h4 class="title">Participants</h4> <p>Adults with focal pancreatic lesions.</p> </section> <section id="CD010213-sec-0043"> <h4 class="title">Index tests</h4> <p>CT scan, MRI scan, PET scan, EUS, EUS elastography, and EUS‐guided biopsy either alone or in combination as replacement for major surgery for diagnostic purposes. </p> <p>We accepted the criteria stated by the authors to classify the lesion as benign, precancerous, and cancerous for different imaging modalities. </p> <p>There is no standard algorithm in the diagnosis or management of focal pancreatic lesions. Other tests that may be used in the diagnosis of focal pancreatic lesions include diagnostic laparoscopy, laparoscopic ultrasound, serum levels of CA 19‐9, and surgical resection (surgical resection may be considered diagnostic when the diagnosis is uncertain after all other diagnostic modalities have been attempted). </p> </section> <section id="CD010213-sec-0044"> <h4 class="title">Target conditions</h4> <p> <ol id="CD010213-list-0004"> <li> <p>Benign versus precancerous and cancerous lesions (including the type of cancerous lesion). </p> </li> <li> <p>Benign and precancerous versus cancerous lesions.</p> </li> </ol> </p> </section> <section id="CD010213-sec-0045"> <h4 class="title">Reference standards</h4> <p>We accepted the following reference standards.</p> <p> <ul id="CD010213-list-0005"> <li> <p>Histopathological examination of the entire lesion by surgical resection (gold standard). This classified the lesion as benign, precancerous, or cancerous. </p> </li> <li> <p>Histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in people with positive test (for cancerous or precancerous lesions) and clinical follow‐up by a doctor (with or without sequential follow‐up with imaging but using appropriate criteria such as metastases or confirmation of cancer by biopsy or death of participants due to cancer) of all participants with negative test for a period of at least six months and for a maximum period of 24 months. Until a definitive diagnosis is available, percutaneous biopsy is generally avoided because of the fear of seeding of cancer cells in potentially resectable cancers. As anticipated, the tissues obtained for histopathological examination were obtained from surgical resection. It is unlikely that patients with a low likelihood for cancer based on clinical symptoms and signs and test results (may include the results of index test) are subject to surgery or biopsy. Even if a biopsy is performed in such patients, a cancerous or precancerous lesion cannot be ruled out because of sampling error. Consequently, such patients are usually followed up clinically with sequential imaging. Pancreatic adenocarcinoma will cause clinical deterioration or increase in tumour size during a period of six months, and so we accepted clinical follow‐up or sequential follow‐up imaging (irrespective of the modality of the imaging) of all participants with a negative biopsy or no biopsy for at least six months as one of the reference standards. However, we accepted clinical follow‐up as a reference standard only when the criteria used for diagnosis were appropriate (e.g. identification of metastases, later biopsy of the lesion confirming the nature of the lesion, and death of participants due to cancer). The choice of a maximum period of 24 months was an arbitrary choice based on the low probability of precancerous lesions becoming cancerous during 24 months. Clinical follow‐up of patients is unlikely to classify precancerous lesions correctly since patients are unlikely to develop metastases or die within this interval. </p> </li> </ul> </p> </section> </section> <section id="CD010213-sec-0046"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010213-sec-0047"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases.</p> <p> <ol id="CD010213-list-0006"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library (Issue 7, 2016) (<a href="./appendices#CD010213-sec-0088">Appendix 2</a>). </p> </li> <li> <p>MEDLINE via PubMed (January 1946 to 19 July 2016) (<a href="./appendices#CD010213-sec-0089">Appendix 3</a>). </p> </li> <li> <p>Embase via OvidSP (January 1947 to 19 July 2016) (<a href="./appendices#CD010213-sec-0090">Appendix 4</a>). </p> </li> <li> <p>Science Citation Index Expanded via ISI Web of Knowledge (January 1980 to 19 July 2016) (<a href="./appendices#CD010213-sec-0091">Appendix 5</a>). </p> </li> </ol> </p> </section> <section id="CD010213-sec-0048"> <h4 class="title">Searching other resources</h4> <p>We searched the references of included studies to identify further studies (<a href="./references#CD010213-bbs2-0949" title="HorsleyT , DingwallO , SampsonM . Checking reference lists to find additional studies for systematic reviews. Cochrane Database of Systematic Reviews2011, Issue 8. [DOI: 10.1002/14651858.MR000026] ">Horsley 2011</a>). We also searched for additional articles related to the included studies by performing the 'related search' function in MEDLINE (PubMed) and Embase (OvidSP) and 'citing reference' search (search the articles that cited the included articles) in Science Citation Index Expanded and Embase (OvidSP) (<a href="./references#CD010213-bbs2-0973" title="SampsonM , ShojaniaKG , McGowanJ , DanielR , RaderT , IansavicheneAE , et al. Surveillance search techniques identified the need to update systematic reviews. Journal of Clinical Epidemiology2008;61(8):755‐62. ">Sampson 2008</a>). </p> </section> </section> <section id="CD010213-sec-0049"> <h3 class="title" id="CD010213-sec-0049">Data collection and analysis</h3> <section id="CD010213-sec-0050"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently searched the references to identify relevant studies. We obtained the full text of references that at least one of the review authors consider relevant and used these full texts to further exclude irrelevant references. We selected references to studies that met the inclusion criteria for data extraction. Any differences in study selection were arbitrated by review author BR Davidson. </p> </section> <section id="CD010213-sec-0051"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted the following data from each included study.</p> <p> <ul id="CD010213-list-0007"> <li> <p>First author of report.</p> </li> <li> <p>Year of publication of report.</p> </li> <li> <p>Study design (prospective or retrospective; cross‐sectional studies or randomised clinical trials). </p> </li> <li> <p>Inclusion and exclusion criteria for individual studies.</p> </li> <li> <p>Total number of participants.</p> </li> <li> <p>Number of females.</p> </li> <li> <p>Mean age of the participants.</p> </li> <li> <p>Criteria used for classification of lesions.</p> </li> <li> <p>Preoperative tests carried out prior to index test.</p> </li> <li> <p>Index test.</p> </li> <li> <p>Reference standard.</p> </li> <li> <p>True positive (TP), false positive (FP), true negative (TN), and false negative (FN) data. </p> </li> </ul> </p> <section id="CD010213-sec-0052"> <h5 class="title">Main analysis</h5> <p>The unit of analysis was the participant. We extracted the TP, FP, TN, and FN information for each index test for the following situations (when data were available). </p> <p> <ol id="CD010213-list-0008"> <li> <p>Precancerous or cancerous lesions (positive test) versus benign lesions with no cancer potential (negative test) (this helps determine whether the patient needs further follow‐up). </p> </li> <li> <p>Cancerous lesions (positive test) versus non‐cancerous lesions (negative test) (this helps determine whether the patient needs immediate surgery). </p> </li> <li> <p>In the group of participants with precancerous or cancerous lesions (i.e. those with positive test in the analysis of benign lesions with no cancer potential (negative test) versus precancerous or cancerous lesions (positive test)), we extracted the TP, FP, TN, and FN information for cancerous lesions (positive test) versus precancerous lesions (negative test) (this helps in assessing whether or not surgery is appropriate; surgery is the only curative option for cancerous lesions, while follow‐up may be an option for precancerous lesions). </p> </li> </ol> </p> <p>We extracted the information on indeterminate results separately from the TP, FP, TN, and FN data. There is no standard algorithm of management of patients with indeterminate results in the first scan. Some surgeons may recommend surgical resection for indeterminate lesions, while others may advise additional scans or sequential follow‐up imaging. We therefore planned to perform a sensitivity analysis as described in <a href="#CD010213-sec-0056">Sensitivity analyses</a>. </p> <p>For tests performed for sequential follow‐up imaging (repeated‐testing strategy), we planned to extract the TP, FP, TN, and FN data for the strategy as a whole. We considered increase in size or change in the lesion on sequential follow‐up imaging (performed within 12 months) a positive index test. If the lesion remained static (or decreased in size) without any change in the characteristics of the lesion, we considered this a negative index test. The majority of surgeons will recommend further follow‐up imaging or no follow‐up if the sequential follow‐up image shows no change in the lesion, and there is no clinical deterioration for the comparison between precancerous and cancerous lesions. We therefore considered indeterminate results on sequential follow‐up imaging as negative results for this comparison. </p> <p>We sought further information from study authors where necessary. Any differences between the review authors were resolved by discussion. </p> </section> </section> <section id="CD010213-sec-0053"> <h4 class="title">Assessment of methodological quality</h4> <p>Two review authors independently assessed the quality of the studies using the QUADAS‐2 assessment tool (<a href="./references#CD010213-bbs2-0981" title="WhitingPF , WeswoodME , RutjesAW , ReitsmaJB , BossuytPN , KleijnenJ . Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Medical Research Methodology2006;6:9. ">Whiting 2006</a>; <a href="./references#CD010213-bbs2-0982" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine2011;155(8):529‐36. ">Whiting 2011</a>). We resolved any differences in assessment using the QUADAS‐2 assessment algorithm published in the protocol. We sought further information from the authors of the studies in order to accurately assess the methodological quality of the studies. </p> <p>We assessed the quality items derived from the QUADAS‐2 tool using the methodology stated in <a href="#CD010213-tbl-0002">Table 1</a>. </p> <div class="table" id="CD010213-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">QUADAS‐2 classification</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Domain</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Signalling question</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Signalling question</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Signalling question</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Risk of bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Concerns for <br/> applicability</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>1: Patient sampling</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a consecutive or random sample of patients enrolled?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a case‐control design avoided?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did the study avoid inappropriate exclusions?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the selection of participants have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Are there concerns that the included participants and setting do not match the review question? </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: all consecutive patients or random sample of patients with focal pancreatic lesions were enrolled </p> <p>No: selected patients were enrolled</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: case‐control design was avoided</p> <p>No: case‐control design was not avoided</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: the study avoided inappropriate exclusions (i.e. difficult‐to‐diagnose patients)</p> <p>No: the study excluded patients inappropriately</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 signalling question</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low concern: the selected participants represent the patients in whom the tests will be used in clinical practice (please see diagnostic pathway (<a href="#CD010213-fig-0001">Figure 1</a>)) </p> <p>High concern: there is high concern that participant selection was performed in such a way that the included participants did not represent the patients in whom the tests will be used in clinical practice </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>2: Index test(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the index test results interpreted without knowledge of the results of the reference standard? </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If a threshold was used, was it prespecified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the conduct or interpretation of the index test have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Are there concerns that the index test, its conduct, or its interpretation differ from the review question? </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: index test results were interpreted without knowledge of the results of the reference standard </p> <p>No: index test results were interpreted with knowledge of the results of the reference standard </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: if the criteria for a positive test were prespecified</p> <p>No: if the criteria for a positive test were not prespecified</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 of the 2 signalling questions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High concern: there is high concern that the conduct or interpretation of the index test differs from the way it is likely to be used in clinical practice </p> <p>Low concern: there is low concern that the conduct or interpretation of the index test differs from the way it is likely to be used in clinical practice </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>3: Target condition and reference standard(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Is the reference standard likely to classify the target condition correctly?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the reference standard results interpreted without knowledge of the results of the index tests? </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the reference standard, its conduct, or its interpretation have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Are there concerns that the target condition as defined by the reference standard does not match the review question? </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: histopathological examination of the entire lesion by surgical resection</p> <p>No: histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) and clinical follow‐up by a doctor (with or without sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months and for a maximum period of 24 months </p> <p>Unclear: this was not clear from the report. Such studies will be excluded</p> <p>Yes: reference standard results were interpreted without knowledge of the results of the index test </p> <p>No: reference standard results were interpreted with knowledge of the results of the index test </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 of the 2 signalling questions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low concern: histopathological examination of the entire lesion by surgical resection</p> <p>High concern: histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) and clinical follow‐up by a doctor (with or without sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months and for a maximum period of 24 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>4: Flow and timing</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was there an appropriate interval between index test and reference standard?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did all patients receive the same reference standard?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were all patients included in the analysis?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the patient flow have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes:</p> <p>histopathological examination of the entire lesion (gold standard) ‐ performed within 2 months (chosen arbitrarily). </p> <p>Histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) performed within 2 months and clinical follow‐up (including sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months </p> <p>No:</p> <p>the histopathological examination was performed beyond 2 months of the index tests.</p> <p>The clinical follow‐up (including sequential follow‐up imaging) was performed less than 6 months after the index test, because some tumours may be slow‐growing </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: histopathological examination of the entire lesion by surgical resection</p> <p>No: histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) and clinical follow‐up by a doctor (with or without sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months and for a maximum period of 24 months </p> <p>Unclear: this was not clear from the report. Such studies will be excluded</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: all patients meeting the selection criteria (selected participants) were included in the analysis, or data on all of the selected participants were available so that a 2 x 2 table including all selected participants could be constructed </p> <p>No: not all patients meeting the selection criteria were included in the analysis, or the 2 x 2 table could not be constructed using data on all selected participants </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 signalling question</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD010213-sec-0054"> <h4 class="title">Statistical analysis and data synthesis</h4> <p>We have plotted study estimates of sensitivity and specificity on forest plots and in receiver operating characteristic (ROC) space to explore between‐study variation in the performance of each test. To estimate the summary sensitivity and specificity of each test, we planned to perform the meta‐analysis by fitting the bivariate model (<a href="./references#CD010213-bbs2-0932" title="ChuH , ColeSR . Bivariate meta‐analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. Journal of Clinical Epidemiology2006;59(12):1331‐2. ">Chu 2006</a>; <a href="./references#CD010213-bbs2-0971" title="ReitsmaJB , GlasAS , RutjesAW , ScholtenRJ , BossuytPM , ZwindermanAH . Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology2005;58(10):982‐90. ">Reitsma 2005</a>), which accounts for between‐study variability in estimates of sensitivity and specificity through the inclusion of random effects for the logit sensitivity and logit specificity parameters of the bivariate model. As there was lack of convergence due to sparse data, we tried other alternate models suggested by <a href="./references#CD010213-bbs2-0978" title="TakwoingiY , GuoB , RileyRD , DeeksJJ . Performance of methods for meta‐analysis of diagnostic test accuracy with few studies or sparse data. Statistical methods in medical research 2015 Jun 26 [Epub ahead of print]. [DOI: 10.1177/0962280215592269] ">Takwoingi 2015</a> and colleagues. These included the random‐effects model, ignoring the inverse correlation between sensitivities and specificities in the different studies due to intrinsic threshold effect, and the fixed‐effect model for either sensitivity or specificity or both after visualising the forest plots and summary receiver operating characteristics (SROC) plots (<a href="./references#CD010213-bbs2-0978" title="TakwoingiY , GuoB , RileyRD , DeeksJJ . Performance of methods for meta‐analysis of diagnostic test accuracy with few studies or sparse data. Statistical methods in medical research 2015 Jun 26 [Epub ahead of print]. [DOI: 10.1177/0962280215592269] ">Takwoingi 2015</a>). We based our choice between the different models on the distribution of sensitivities and specificities as noted in the forest plots or ROC space. We also used the model fit as indicated by the ‐2 log likelihood and considered the model with the lower ‐2 log likelihood to be the better model. </p> <p>We planned to compare the diagnostic accuracy of the tests by including covariate terms for test type (CT scan, MRI, PET, EUS, EUS‐FNA, EUS elastography) in the bivariate model to estimate differences in the sensitivity and specificity of the tests. We planned to allow both the sensitivity and specificity to vary by covariate. In addition, we planned to permit the variances of the random effects and their covariance to also depend on test type, thus allowing the variances to differ between tests. We planned to use likelihood ratio tests to compare the model with and without covariate (test type). We planned to use a P value of less than 0.05 for the likelihood ratio test to indicate differences in the diagnostic accuracy between the tests. If studies that reported different tests in the same study population were available from at least four studies, we planned to perform a direct head‐to‐head comparison by limiting the test comparison to such studies. We planned to calculate the relative sensitivities and specificities for each pair‐wise comparison of tests. </p> <p>We performed the meta‐analysis using the NLMIXED command in SAS version 9.4 (SAS Institute Inc, Cary, North Carolina, USA) (<a href="./references#CD010213-bbs2-0977" title="Takwoingi Y ,  Deeks JJ . Software for meta‐analysis of DTA studies. methods.cochrane.org/sdt/software‐meta‐analysis‐dta‐studies 2010 (accessed 8 April 2016). ">Takwoingi 2012</a>). The post‐test probabilities were calculated using these pre‐test probabilities and the summary positive and negative likelihood ratios. We calculated the summary likelihood ratios and their confidence intervals from the functions of the parameter estimates from the model that we fitted to estimate the summary sensitivities and specificities. Post‐test probability associated with a positive test is the probability of having the target condition (e.g. precancer or cancer) on the basis of a positive test result (e.g. positive CT) and is the same as the term 'positive predictive value' used in a single diagnostic accuracy study. Post‐test probability associated with a negative test is the probability of having the target condition (e.g. precancer or cancer) on the basis of a negative test result (e.g. negative CT) and is 1 ‐ 'negative predictive value'. 'Negative predictive value' is the term used in a single diagnostic accuracy study to indicate the chance that the participant has no target condition when the test is negative. We have reported the summary sensitivity, specificity, and post‐test probabilities for the median pre‐test probabilities whenever possible. </p> </section> <section id="CD010213-sec-0055"> <h4 class="title">Investigations of heterogeneity</h4> <p>We visually inspected forest plots of sensitivity and specificity and the ROC curve to identify heterogeneity. We planned to explore heterogeneity by using the different sources of heterogeneity as covariates in the METADAS macro (<a href="./references#CD010213-bbs2-0977" title="Takwoingi Y ,  Deeks JJ . Software for meta‐analysis of DTA studies. methods.cochrane.org/sdt/software‐meta‐analysis‐dta‐studies 2010 (accessed 8 April 2016). ">Takwoingi 2012</a>), but due to the sparseness of the data we were unable to do this. We planned to assess whether there was a statistically significant difference in the likelihood ratios in order to identify heterogeneity. Although we did not formally compare the diagnostic test accuracy of different index tests between solid and cystic lesions, we have presented a subgroup analysis of solid and cystic lesions, since some clinicians consider the diagnostic test accuracies to differ between the two. </p> </section> <section id="CD010213-sec-0056"> <h4 class="title">Sensitivity analyses</h4> <p>In the presence of indeterminate results (for any reason) for the initial test, we planned to consider two scenarios: the participants with indeterminate results as positive for the test, as some surgeons will recommend surgical resection for indeterminate lesions; and the indeterminate results as negative for the test, as some surgeons will recommend sequential follow‐up imaging. We planned to assess the diagnostic accuracy in both of these scenarios. However, due to sparse data and few studies reporting indeterminate results we did not perform the above. </p> <p>We also planned to assess the comparative performance of tests by direct comparison (i.e. the tests performed in the same participant) versus indirect comparison (the tests performed in different participants across studies). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010213-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010213-sec-0057"></div> <section id="CD010213-sec-0058"> <h3 class="title" id="CD010213-sec-0058">Results of the search</h3> <p>We identified 33,795 references through electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and Science Citation Index. We were left with 24,799 references after removing duplicate references. We excluded 23,879 clearly irrelevant references through reading the abstracts. We sought the full text for 920 references for further assessment. We did not identify any additional references to studies through other searches. We excluded 866 references for the reasons described in the <a href="./references#CD010213-sec-0100" title="">Characteristics of excluded studies</a> tables. Fifty‐two studies (54 references) met the inclusion criteria. Two studies reported the diagnostic test data on solid and cystic lesions separately (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>)therefore, we considered them as separate studies. We thus included a total of 54 studies in the review (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). The reference flow diagram is shown in <a href="#CD010213-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD010213-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD010213-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <section id="CD010213-sec-0059"> <h4 class="title">Characteristics of included studies</h4> <p>For a summary of the characteristics of included studies see the <a href="./references#CD010213-sec-0099" title="">Characteristics of included studies</a> table. </p> <p>We included a total of 54 studies involving 31,196 participants in this systematic review. The studies reported investigation of eight different target conditions: </p> <p> <ul id="CD010213-list-0009"> <li> <p>cancerous versus benign or precancerous lesions;</p> </li> <li> <p>cancerous versus benign lesions;</p> </li> <li> <p>precancerous or cancerous lesions versus benign lesions;</p> </li> <li> <p>cancerous (invasive carcinoma) versus precancerous (dysplasia) lesions;</p> </li> <li> <p>cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) lesions; </p> </li> <li> <p>cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) lesions;</p> </li> <li> <p>precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) lesions; and </p> </li> <li> <p>precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign lesions. </p> </li> </ul> </p> <p>The variation in target condition was due to different definitions of what constitutes a benign, precancerous, and cancerous lesion. For example, the World Health Organization pancreatic tumour classification system classifies intraductal papillary mucinous neoplasms' (IPMNs) as precancerous tumours regardless of dysplasia (<a href="./references#CD010213-bbs2-0955" title="LuttgesJ . What's new? The 2010 WHO classification for tumours of the pancreas. Pathologe2011;32 Suppl 2:332‐6. ">Luttges 2011</a>). However, many of the included studies considered IPMNs to be benign lesions or even classified them as benign or cancerous based on the grade of dysplasia. This meant that the index tests were actually used for differentiating between very different populations of cancerous and benign tumours, and therefore the combination of all studies as simply cancer versus benign would have been inappropriate. In addition, different surgeons will have different thresholds for recommending surgery. Consequently, we have presented the results for all of the various definitions used by authors to classify a lesion as benign, precancerous, or cancerous. </p> <p>Three studies reported data on tests differentiating cancerous from benign or precancerous lesions. Of these three studies, one reported the performance of EUS‐FNA using cytology (<a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>); another reported the performance of EUS‐FNA using a carcinoembryonic antigen (CEA) threshold of 500 ng/mL (<a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>); and the third reported the performance of PET to differentiate between benign or precancerous and cancerous lesions (<a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>). The median pre‐test probability of a cancerous lesion in these studies was 0.625 or 62.5% (minimum 0.533, maximum 0.711). </p> <p>Twelve studies reported data on tests differentiating cancerous from benign lesions. Of these 12 studies, two reported the performance of EUS (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>); three reported the performance of EUS‐FNA (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>); three reported the performance of PET (<a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>); one reported the performance of PET with a standard uptake value (SUV) maximum of greater than 3.5 as its threshold for positivity (<a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>); two reported the performance of CT (<a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>); and one reported the performance of MRI to differentiate between cancerous and benign lesions (<a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>). The median pre‐test probability of a cancerous lesion in these studies was 0.697 or 69.7% (minimum 0.231, maximum 0.889). </p> <p>Six studies reported data on tests differentiating precancerous or cancerous from benign lesions, with one study providing data for multiple imaging modalities (<a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>). One study reported the performance of EUS (<a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>); three studies reported the performance of EUS‐FNA (<a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>); one study reported the performance of EUS‐FNA using a CEA threshold of 50 ng/mL (<a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>); one study reported the performance of PET with an SUV maximum threshold of greater than 2.4 as its threshold for positivity (<a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>); one study reported the performance of CT (<a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>); and one study reported the performance of MRI (<a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>). The median pre‐test probability of a precancerous or cancerous lesion in these studies was 0.706 or 70.6% (minimum 0.519, maximum 0.75). </p> <p>Twelve studies reported data on tests differentiating cancerous invasive carcinomas from precancerous dysplastic lesions, with some studies reporting the diagnostic test accuracy or more than one index test. Five studies reported the performance of EUS (<a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>); three studies reported the performance of EUS‐FNA (<a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>); and one study reported the performance of EUS‐FNA using a CEA threshold of 200 ng/mL (<a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>). Six studies reported the performance of CT (<a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>), and one study reported the performance of MRI (<a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>). The median pre‐test probability of a cancerous invasive carcinoma was 0.270 or 27% (minimum 0.122, maximum 0.618). </p> <p>Eighteen studies reported data on tests differentiating cancerous lesions defined by high‐grade dysplasia or invasive carcinoma from precancerous lesions with a low or intermediate grade of dysplasia, with some studies reporting the diagnostic test accuracy or more than one index test. Four studies reported the performance of EUS (<a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>). Three studies reported the performance of EUS‐FNA (<a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). Three studies reported the performance of EUS‐FNA using a CEA threshold of 200 ng/mL (<a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>). One study reported the performance of EUS‐FNA using a carbohydrate antigen 19‐9 threshold of greater than 1000 U/mL (<a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>). One study reported the performance of EUS‐FNA using a CEA threshold of 692.8 ng/mL (<a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). Four studies reported the performance of PET with an SUVmax value between 2 and 2.5 as their threshold for positivity (<a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>). Three studies reported the performance of CT (<a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>). Three studies reported the performance of MRI (<a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>). The median pre‐test probability of a cancerous lesion defined by high‐grade dysplasia or invasive carcinoma in these studies was 0.449 or 44.9% (minimum 0.167, maximum 0.875). </p> <p>Two studies reported data on tests differentiating cancerous invasive carcinomas from precancerous lesions with a low grade of dysplasia. One study reported the performance of EUS (<a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>), and one study reported the performance of CT (<a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>). The median pre‐test probability of cancerous invasive carcinoma in these studies was 0.214 or 21.4% (minimum 0.174, maximum 0.255). </p> <p>Five studies reported data on tests differentiating precancerous or cancerous lesions that may be moderately or highly dysplastic or invasive carcinomas from precancerous lesions with a low grade of dysplasia. Three studies reported the performance of CT (<a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>), and two studies reported the performance of MRI (<a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>). None of the studies reported the diagnostic accuracy of EUS elastography or sequential testing. The median pre‐test probability of a cancerous lesion that may be moderately or highly dysplastic or an invasive carcinoma in these studies was 0.593 or 59.3% (minimum 0.574, maximum 0.68). </p> <p>One study reported data on tests differentiating precancerous or cancerous lesions that may be moderately or highly dysplastic or invasive carcinomas from benign or precancerous lesions with a low grade of dysplasia. This study reported the performance of EUS. The median pre‐test probability of a cancerous lesion that may be moderately or highly dysplastic or an invasive carcinoma in this study was 0.429 or 42.9%. </p> <p>Forty‐six studies were full‐text publications (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>; <a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). The remaining studies were abstracts (<a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>). Three studies were prospective (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>); 39 were retrospective (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>); and 12 did not state whether they were prospective or retrospective (<a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>). </p> <p>None of the studies reported data on symptomatic and asymptomatic participants separately. Forty‐two studies (2086 participants) reported on cystic pancreatic lesions (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). Four studies reported on solid pancreatic lesions (<a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>). The remaining eight studies either did not mention whether the lesions were cystic or solid, or did not report this information separately (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>). None of the studies reported data on people with chronic pancreatitis separately. </p> <p>Overall, 12 studies reported data on EUS results (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>); 19 studies reported data on EUS‐FNA (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>); 10 studies reported data on PET (<a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>); 13 studies reported data on CT (<a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>); and eight studies reported data on MRI (<a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>). </p> <p>The criteria for a positive test result varied widely by study and are described in detail in <a href="./references#CD010213-sec-0099" title="">Characteristics of included studies</a>. The reference standards in all of the included studies was surgical excision. </p> </section> </section> <section id="CD010213-sec-0060"> <h3 class="title">Methodological quality of included studies</h3> <p>The methodological quality of the included studies is summarised in <a href="#CD010213-fig-0003">Figure 3</a> and <a href="#CD010213-fig-0004">Figure 4</a>. None of the included studies was of high methodological quality. </p> <div class="figure" id="CD010213-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies." data-id="CD010213-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies. </p> </div> </div> </div> <div class="figure" id="CD010213-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study." data-id="CD010213-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study. </p> </div> </div> </div> <section id="CD010213-sec-0061"> <h4 class="title">Participant selection domain</h4> <p>In the participant selection domain, nine studies had a low risk of bias (<a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>). All of the studies had high applicability concerns because of concerns that the participants did not match the review question. The review question was to find out the diagnostic accuracy of these index tests in people with focal lesions. However, all of the studies meeting the inclusion criteria for this review except <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a> used surgical excision as the reference standard, suggesting that the surgeons considered these patients to be at high risk of malignancy based on the results of the index tests or the tests that patients had prior to or subsequent to the index test. <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a> was also at high risk of applicability concern because it excluded participants with resectable lesions on CT scan and included only those equivocal lesions on CT scan. </p> </section> <section id="CD010213-sec-0062"> <h4 class="title">Index test domain</h4> <p>In the index test domain, nine studies were at low risk of bias (<a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>). Of the remaining studies, 31 were at unclear risk of bias because it was unclear whether the index test results were interpreted without knowledge of the results of the reference standard (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). Fifteen studies were at high risk of bias because the threshold for the index test was not prespecified (<a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). Twenty‐eight studies had low applicability concerns (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>), and the remaining 27 studies had high applicability concerns because of concerns that the index test, its conduct, or interpretation differed from the review question (<a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>). </p> </section> <section id="CD010213-sec-0063"> <h4 class="title">Reference standard domain</h4> <p>In the reference standard domain, three studies were at low risk of bias (<a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>). Two studies were at high risk of bias because the reference standard results were not interpreted without knowledge of the index test results (<a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>), or because radiological and clinical follow‐up was used in some of the participants as the reference standard. The remaining 49 studies were at unclear risk of bias as it was unclear if the reference standard was interpreted without knowledge of the results of index tests (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). All studies were at low concern for applicability, as we considered the definition of the target condition by the reference standard to match the review question. </p> </section> <section id="CD010213-sec-0064"> <h4 class="title">Flow and timing domain</h4> <p>None of the studies were at low risk of bias in the flow and timing domain. Thirty studies were at high risk of bias because not all of the participants were included in the analysis, or there was an inappropriate interval between the index test and reference standard (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>; <a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0023" title="JinDX , SmallAJ , VollmerCM , JhalaN , FurthEE , GinsbergGG , et al. A lower cyst fluid CEA cut‐off increases diagnostic accuracy in identifying mucinous pancreatic cystic lesions. Journal of the Pancreas2015;16(3):271‐7. ">Jin 2015</a>; <a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>; <a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>). One study was at high risk of bias because the reference standards that participants received were dependent on the index test results. The remaining 23 studies were at unclear risk of bias because it was either unclear if there was an appropriate interval between the index test and reference standard or if all participants were included in the analysis, or both (<a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>; <a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>; <a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>; <a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). </p> </section> </section> <section id="CD010213-sec-0065"> <h3 class="title" id="CD010213-sec-0065">Findings</h3> <p>The results are summarised in the <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. The overall sensitivities and specificities for different tests for different target conditions are tabulated in <a href="#CD010213-tbl-0003">Table 2</a>. A detailed description is given below. </p> <div class="table" id="CD010213-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary sensitivity and specificity of different tests for different target conditions</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name of test</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign or precancerous</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (95% CI 0.60 to 0.91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.85 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign or precancerous</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 500 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.70 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33 (95% CI 0.12 to 0.65)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign or precancerous</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET<br/> (criteria unspecified) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (95% CI 0.73 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.72 to 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (95% CI 0.84 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.53 (95% CI 0.31 to 0.74)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (95% CI 0.07 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.91 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET (criteria unspecified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.80 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.65 (95% CI 0.39 to 0.85)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET (SUVmax &gt; 3.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (95% CI 0.87 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (95% CI 0.43 to 0.78)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98 (95% CI 0.00 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 (95% CI 0.02 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80 (95% CI 0.58 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (95% CI 0.57 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.74 to 0.98)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60 (95% CI 0.31 to 0.83)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA (cytology)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73 (95% CI 0.01 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (95% CI 0.15 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 50 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29 (95% CI 0.08 to 0.64)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25 (95% CI 0.05 to 0.70)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET<br/> (SUVmax 2.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (95% CI 0.74 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.69 to 0.99)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (95% CI 0.45 to 0.76)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (95% CI 0.39 to 0.84)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.69 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (95% CI 0.58 to 0.96)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (95% CI 0.45 to 0.94)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.61 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.66 (95% CI 0.03 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.73 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.57 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (95% CI 0.48 to 0.78)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (95% CI 0.50 to 0.87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.81 to 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.75 (95% CI 0.30 to 0.95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.77 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (95% CI 0.74 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.83 to 0.96)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.47 (95% CI 0.24 to 0.70)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.32 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.58 (95% CI 0.28 to 0.83)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.51 (95% CI 0.19 to 0.81)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CA 19‐9 &gt; 1000 U/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (95% CI 0.60 to 0.98)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (95% CI 0.26 to 0.59)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 692.8 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80 (95% CI 0.49 to 0.94)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (95% CI 0.60 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET<br/> (SUVmax &gt; 2 to 2.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (95% CI 0.79 to 0.96)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (95% CI 0.81 to 0.99)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (95% CI 0.00 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (95% CI 0.00 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (95% CI 0.44 to 0.86)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.43 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (95% CI 0.50 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (95% CI 0.76 to 0.96)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 (95% CI 0.22 to 0.78)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (95% CI 0.83 to 0.99)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (95% CI 0.68 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (95% CI 0.64 to 0.93)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80 (95% CI 0.58 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (95% CI 0.53 to 0.95)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97 (95% CI 0.83 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40 (95% CI 0.26 to 0.55)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cystic lesion subgroup analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign ‐ EUS‐FNA (cytology)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 (95% CI 0.19 to 0.81)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.84 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cystic lesion subgroup analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign ‐ PET<br/> (SUVmax &gt; 3.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (95% CI 0.87 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (95% CI 0.43 to 0.78)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cystic lesion subgroup analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign ‐ EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 (95% CI 0.19 to 0.71)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.74 to 1.00)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CA 19‐9: carbohydrate antigen 19‐9<br/> CEA: carcinoembryonic antigen<br/> CI: confidence interval<br/> CT: computed tomography<br/> EUS: endoscopic ultrasound<br/> FNA: fine‐needle aspiration<br/> MRI: magnetic resonance imaging<br/> PET: positron emission tomography<br/> SUVmax: maximum standardised uptake values </p> </div> </div> <section id="CD010213-sec-0066"> <h4 class="title">Cancerous versus benign or precancerous</h4> <p><b>EUS‐FNA cytology:</b> We included one study reporting data on 45 participants for this test (<a href="./references#CD010213-bbs2-0035" title="McHenryL , DeWittJ , ShermanS , LeBlancJ , McGreedyK , ChriswellM . Mucinous cystic neoplasms of the pancreas: Accuracy of cytology and mucin stain at endoscopic ultrasound‐guided fine‐needle aspiration. Gastrointestinal Endoscopy2002;56(4 Suppl):S118. ">McHenry 2002</a>). The sensitivity and specificity for diagnosing cancer were 0.79 (95% confidence interval (CI) 0.60 to 0.91) and 1.00 (95% CI 0.85 to 1.00), respectively. </p> <p><b>EUS‐FNA (CEA &gt; 500 ng/mL):</b> We included one study reporting data on 24 participants for this test (<a href="./references#CD010213-bbs2-0024" title="KalhaI , KawM , SinghS , PatelM , CohenD , MornsJ , et al. Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration of cystic lesions of the pancreas. Gastroenterology2003;124(4):A188‐A. ">Kalha 2003</a>). The sensitivity and specificity for diagnosing cancer were 0.93 (95% CI 0.70 to 0.99) and 0.33 (95% CI 0.12 to 0.65), respectively. </p> <p><b>PET (criteria: not specified):</b> We included one study reporting data on 76 participants for this test (<a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>). The sensitivity and specificity for diagnosing cancer were 0.85 (95% CI 0.73 to 0.92) and 0.91 (95% CI 0.72 to 0.97), respectively. </p> <p>The results including sensitivities and specificities and post‐test probabilities at median pre‐test probabilities are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising all of the sensitivity and specificity data for the 'cancerous versus benign or precancerous' studies is shown in <a href="#CD010213-fig-0005">Figure 5</a>. </p> <div class="figure" id="CD010213-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot ‐ Cancerous versus benign or precancerous." data-id="CD010213-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Cancerous versus benign or precancerous.</p> </div> </div> </div> </section> <section id="CD010213-sec-0067"> <h4 class="title">Cancerous versus benign</h4> <p><b>EUS:</b> Two studies reporting data on 133 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>). The summary sensitivity and summary specificity for diagnosing cancer were 0.95 (95% CI 0.84 to 0.99) and 0.53 (95% CI 0.31 to 0.74), respectively. </p> <p><b>EUS‐FNA cytology:</b> Three studies reporting data on 147 participants were included for this test (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a>). The sensitivity and specificity for diagnosing cancer were 0.79 (95% CI 0.07 to 1.00) and 1.00 (95% CI 0.91 to 1.00), respectively. </p> <p><b>PET (criteria: not specified):</b> Three studies reporting data on 99 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>). The summary sensitivity and summary specificity for diagnosing cancer were 0.92 (95% CI 0.80 to 0.97) and 0.65 (95% CI 0.39 to 0.85), respectively. </p> <p><b>PET (SUVmax &gt; 3.5):</b> We included one study reporting data on 80 participants for this test (<a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>). The sensitivity and specificity for diagnosing cancer were 0.96 (95% CI 0.87 to 0.99) and 0.62 (95% CI 0.43 to 0.78), respectively. </p> <p><b>CT:</b> Two studies reporting data on 123 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>). The summary sensitivity and summary specificity for diagnosing cancer were 0.98 (95% CI 0.00 to 1.00) and 0.76 (95% CI 0.02 to 1.00), respectively. </p> <p><b>MRI:</b> We included one study reporting data on 29 participants for this test (<a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>). The sensitivity and specificity for diagnosing cancer were 0.80 (95% CI 0.58 to 0.92) and 0.89 (95% CI 0.57 to 0.98), respectively. </p> <p>The results including sensitivities and specificities and post‐test probabilities at median pre‐test probabilities are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising all of the sensitivity and specificity data for the 'cancerous versus benign' studies is shown in <a href="#CD010213-fig-0006">Figure 6</a>. </p> <div class="figure" id="CD010213-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot ‐ Cancerous versus benign." data-id="CD010213-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Cancerous versus benign.</p> </div> </div> </div> </section> <section id="CD010213-sec-0068"> <h4 class="title">Precancerous or cancerous versus benign</h4> <p><b>EUS:</b> We included one study reporting data on 34 participants for this test (<a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>). The sensitivity and specificity for diagnosing cancer or precancer were 0.92 (95% CI 0.74 to 0.98) and 0.60 (95% CI 0.31 to 0.83), respectively. </p> <p><b>EUS‐FNA cytology:</b> We included three studies, reporting data on 52 participants for this test (<a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>). The summary sensitivity and summary specificity for diagnosing cancer or precancer were 0.73 (95% CI 0.01 to 1.00) and 0.94 (95% CI 0.15 to 1.00), respectively. </p> <p><b>EUS‐FNA (CEA &gt; 50 ng/mL):</b> We included one study reporting data on 11 participants for this test (<a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>). The sensitivity and specificity for diagnosing cancer or precancer were 0.29 (95% CI 0.08 to 0.64) and 0.25 (95% CI 0.05 to 0.70), respectively. </p> <p><b>PET (SUVmax &gt; 2.4):</b> We included one study reporting data on 32 participants for this test (<a href="./references#CD010213-bbs2-0040" title="OtomiY , OtsukaH , TerazawaK , NoseH , KuboM , MatsuzakiK , et al. Comparing the performance of visual estimation and standard uptake value of f‐18 fluorodeoxyglucose positron emission tomography/computed tomography for detecting malignancy in pancreatic tumors other than invasive ductal carcinoma. Journal of Medical Investigation2014;61(1‐2):171‐9. ">Otomi 2014</a>). The sensitivity and specificity for diagnosing cancer or precancer were 0.94 (95% CI 0.74 to 0.99) and 0.93 (95% CI 0.69 to 0.99), respectively. </p> <p><b>CT:</b> We included one study reporting data on 48 participants for this test (<a href="./references#CD010213-bbs2-0013" title="FisherWE , HodgesSE , YagnikV , MoronFE , WuMF , HilsenbeckSG , et al. Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasms. HPB2008;10(6):483‐90. ">Fisher 2008</a>). The sensitivity and specificity for diagnosing cancer or precancer were 0.62 (95% CI 0.45 to 0.76) and 0.64 (95% CI 0.39 to 0.84), respectively. </p> <p><b>MRI:</b> We included one study reporting data on 27 participants for this test (<a href="./references#CD010213-bbs2-0020" title="JangKM , KimSH , LeeSJ , ChoiD . The value of gadoxetic acid‐enhanced and diffusion‐weighted MRI for prediction of grading of pancreatic neuroendocrine tumors. Acta Radiologica2014;55(2):140‐8. ">Jang 2014a</a>). The sensitivity and specificity for diagnosing cancer or precancer were 0.93 (95% CI 0.69 to 0.99) and 0.85 (95% CI 0.58 to 0.96), respectively. </p> <p>The results including sensitivities and specificities and post‐test probabilities at median pre‐test probabilities are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising all of the sensitivity and specificity data for the 'precancerous or cancerous versus benign' studies is shown in <a href="#CD010213-fig-0007">Figure 7</a>. </p> <div class="figure" id="CD010213-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot ‐ Precancerous or cancerous versus benign." data-id="CD010213-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Precancerous or cancerous versus benign.</p> </div> </div> </div> </section> <section id="CD010213-sec-0069"> <h4 class="title">Cancerous (invasive carcinoma) versus precancerous (dysplasia)</h4> <p><b>EUS:</b> Five studies reporting data on 156 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>; <a href="./references#CD010213-bbs2-0053" title="ZhanXB , XieB , MaD , LiZS . Value of endoscopic ultrasonographic features in predicting the malignancy of pancreatic mucinous cystic neoplasms and intraductal papillary mucinous neoplasms. Gut2011;60:A202. ">Zhan 2011</a>). The summary sensitivity and summary specificity for diagnosing invasive cancer were 0.78 (95% CI 0.45 to 0.94) and 0.91 (95% CI 0.61 to 0.98), respectively. </p> <p><b>EUS‐FNA cytology:</b> Three studies reporting data on 158 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0041" title="PaisSA , AttasaranyaS , LeblancJK , ShermanS , SchmidtCM , DeWittJ . Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clinical Gastroenterology &amp; Hepatology2007;5(4):489‐95. ">Pais 2007</a>; <a href="./references#CD010213-bbs2-0044" title="SallaC , ChatzipantelisP , KonstantinouP , KaroumpalisI , SakellariouS , PantazopoulouA , et al. Endoscopic ultrasound‐guided fine‐needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. JOP: Journal of the Pancreas2007;8(6):715‐24. ">Salla 2007</a>). The summary sensitivity and summary specificity for diagnosing invasive cancer were 0.66 (95% CI 0.03 to 0.99) and 0.92 (95% CI 0.73 to 0.98), respectively. </p> <p><b>EUS‐FNA (CEA &gt; 200 ng/mL):</b> We included one study reporting data on 41 participants for this test (<a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>). The sensitivity and specificity for diagnosing invasive cancer were 1.00 (95% CI 0.57 to 1.00) and 0.64 (95% CI 0.48 to 0.78), respectively. </p> <p><b>CT:</b> Six studies reporting data on 326 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0004" title="CellierC , CuillerierE , PalazzoL , RickaertF , FlejouJF , NapoleonB , et al. Intraductal papillary and mucinous tumors of the pancreas: Accuracy of preoperative computed tomography, endoscopic retrograde pancreatography and endoscopic ultrasonography, and long‐term outcome in a large surgical series. Gastrointestinal Endoscopy1998;47(1):42‐9. ">Cellier 1998</a>; <a href="./references#CD010213-bbs2-0036" title="NakagawaA , YamaguchiT , OhtsukaM , IshiharaT , SudoK , NakamuraK , et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single‐detector computed tomography and endoscopic ultrasonography. Pancreas2009;38(2):131‐6. ">Nakagawa 2009</a>; <a href="./references#CD010213-bbs2-0037" title="NaraS , OnayaH , HiraokaN , ShimadaK , SanoT , SakamotoY , et al. Preoperative evaluation of invasive and noninvasive intraductal papillary‐mucinous neoplasms of the pancreas: Clinical, radiological, and pathological analysis of 123 cases. Pancreas2009;38(1):8‐16. ">Nara 2009</a>; <a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0050" title="TaouliB , VilgrainV , VulliermeMP , TerrisB , DenysA , SauvanetA , et al. Intraductal papillary mucinous tumors of the pancreas: Helical CT with histopathologic correlation. Radiology2000;217(3):757‐64. ">Taouli 2000</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>). The summary sensitivity and summary specificity for diagnosing invasive cancer were 0.72 (95% CI 0.50 to 0.87) and 0.92 (95% CI 0.81 to 0.97), respectively. </p> <p><b>MRI:</b> We included one study reporting data on 32 participants for this test (<a href="./references#CD010213-bbs2-0008" title="DeJongK , NioCY , GoumaDJ , BrunoMJ , FockensP . Accuracy of MRI and EUS in a prospective cohort of patients with histological proven pancreatic cystic lesions of the pancreas. Gastroenterology2010;138(5 Suppl 1):S547. deJongK , vanHooftJE , NioCY , GoumaDJ , DijkgraafMG , BrunoMJ , et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scandinavian Journal of Gastroenterology2012;47(8‐9):1056‐63. ">de Jong 2012</a>). The sensitivity and specificity for diagnosing invasive cancer were 0.75 (95% CI 0.30 to 0.95) and 0.93 (95% CI 0.77 to 0.98), respectively. </p> <p>The results including sensitivities and specificities and post‐test probabilities at median pre‐test probabilities are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising all of the sensitivity and specificity data for the 'cancer (invasive carcinoma) versus precancerous (dysplasia)' studies is shown in <a href="#CD010213-fig-0008">Figure 8</a>. </p> <div class="figure" id="CD010213-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (dysplasia)." data-id="CD010213-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (dysplasia).</p> </div> </div> </div> </section> <section id="CD010213-sec-0070"> <h4 class="title">Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </h4> <p><b>EUS:</b> Four studies reporting data on 196 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0009" title="DoiR , FujimotoK , WadaM , ImamuraM . Surgical management of intraductal papillary mucinous tumor of the pancreas. Surgery2002;132(1):80‐5. ">Doi 2002</a>; <a href="./references#CD010213-bbs2-0029" title="KobayashiN , SugimoriK , ShimamuraT , HosonoK , WatanabeS , KatoS , et al. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology2012;12(2):141‐5. ">Kobayashi 2012</a>; <a href="./references#CD010213-bbs2-0033" title="LeeKH , LeeSJ , LeeJK , RyuJK , KimEY , KimTH , et al. Prediction of malignancy with endoscopic ultrasonography in patients with branch duct‐type intraductal papillary mucinous neoplasm. Pancreas2014;43(8):1306‐11. ">Lee 2014</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>). The summary sensitivity and summary specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.86 (95% CI 0.74 to 0.92) and 0.91 (95% CI 0.83 to 0.96), respectively. </p> <p><b>EUS‐FNA cytology:</b> Three studies reporting data on 310 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0022" title="JinDX , JhalaN , ShahPM , BernsteinGR , ChandrasekharaV , GinsbergGG , et al. Cytological atypia does not predict malignancy in pancreatic cystic lesions. Gastroenterology2013;1:S795. ">Jin 2013a</a>; <a href="./references#CD010213-bbs2-0046" title="SmithAL , Abdul‐KarimFW , GoyalA . Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines. Cancer Cytopathology2016;124(4):285‐93. ">Smith 2016</a>; <a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). The summary sensitivity and summary specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.47 (95% CI 0.24 to 0.70) and 0.91 (95% CI 0.32 to 1.00), respectively. </p> <p><b>EUS‐FNA (CEA &gt; 200 ng/mL):</b> Three studies reporting data on 160 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0007" title="Correa‐GallegoC , WarshawAL , Fernandez‐del CastilloC . Fluid CEA in ipmns: A useful test or the flip of a coin?. American Journal of Gastroenterology2009;104(3):796‐7. ">Correa‐Gallego 2009</a>; <a href="./references#CD010213-bbs2-0031" title="KuceraS , CentenoBA , SpringettG , MalafaMP , ChenYA , WeberJ , et al. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas. JOP: Journal of the Pancreas [Electronic Resource]2012;13(4):409‐13. ">Kucera 2012</a>; <a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>). The summary sensitivity and summary specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.58 (95% CI 0.28 to 0.83) and 0.51 (95% CI 0.19 to 0.81), respectively. </p> <p><b>EUS‐FNA (carbohydrate antigen 19‐9 &gt; 1000 U/mL):</b> We included one study reporting data on 41 participants for this test (<a href="./references#CD010213-bbs2-0034" title="MaireF , VoitotH , AubertA , PalazzoL , O'TooleD , CouvelardA , et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. American Journal of Gastroenterology2008;103(11):2871‐7. ">Maire 2008</a>). The sensitivity and specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.90 (95% CI 0.60 to 0.98) and 0.42 (95% CI 0.26 to 0.59), respectively. </p> <p><b>EUS‐FNA (CEA &gt; 692.8 ng/mL):</b> We included one study reporting data on 20 participants for this test (<a href="./references#CD010213-bbs2-0054" title="ZhanXB , WangB , LiuF , YeXF , JinZD , LiZS . Cyst fluid carcinoembryonic antigen concentration and cytology by endosonography‐guided fine needle aspiration in predicting malignant pancreatic mucinous cystic neoplasms. Journal of Digestive Diseases2013;14(4):191‐5. ">Zhan 2013</a>). The sensitivity and specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.80 (95% CI 0.49 to 0.94) and 0.90 (95% CI 0.60 to 0.98), respectively. </p> <p><b>PET (SUVmax 2 to 2.5):</b> Four studies reporting data on 124 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0043" title="SaitoM , IshiharaT , TadaM , TsuyuguchiT , MikataR , SakaiY , et al. Use of f‐18 fluorodeoxyglucose positron emission tomography with dual‐phase imaging to identify intraductal papillary mucinous neoplasm. Clinical Gastroenterology &amp; Hepatology2013;11(2):181‐6. ">Saito 2013</a>; <a href="./references#CD010213-bbs2-0047" title="TakanamiK , HiraideT , TsudaM , NakamuraY , KanetaT , TakaseK , et al. Additional value of FDG PET/CT to contrast‐enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Annals of Nuclear Medicine2011;25(7):501‐10. ">Takanami 2011</a>; <a href="./references#CD010213-bbs2-0051" title="TomimaruY , TakedaY , TatsumiM , KimT , KobayashiS , MarubashiiS , et al. Utility of 2‐[f‐18] fluoro‐2‐deoxy‐d‐glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary‐mucinous neoplasm of the pancreas. Oncology Reports2010;24(3):613‐20. ">Tomimaru 2010</a>). The summary sensitivity and summary specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.90 (95% CI 0.79 to 0.96) and 0.94 (95% CI 0.81 to 0.99), respectively. </p> <p><b>CT:</b> Three studies reporting data on 139 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0017" title="HongHS , YunM , ChoA , ChoiJY , KimMJ , KimKW , et al. The utility of f‐18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clinical Nuclear Medicine2010;35(10):776‐9. ">Hong 2010</a>; <a href="./references#CD010213-bbs2-0032" title="LeBaleurY , CouvelardA , VulliermeMP , SauvanetA , HammelP , ReboursV , et al. Mucinous cystic neoplasms of the pancreas: Definition of preoperative imaging criteria for high‐risk lesions. Pancreatology2011;11(5):495‐9. ">Le Baleur 2011a</a>; <a href="./references#CD010213-bbs2-0052" title="YamaoK , OhashiK , NakamuraT , SuzukiT , WatanabeY , ShimizuY , et al. Evaluation of various imaging methods in the differential diagnosis of intraductal papillary‐mucinous tumor (IPMT) of the pancreas. Hepato‐Gastroenterology2001;48(40):962‐6. ">Yamao 2001</a>). The summary sensitivity and summary specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.87 (95% CI 0.00 to 1.00) and 0.96 (95% CI 0.00 to 1.00), respectively. </p> <p><b>MRI:</b> Three studies reporting data on 189 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0021" title="JangKM , KimSH , MinJH , LeeSJ , KangTW , LimS , et al. Value of diffusion‐weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas. AJR American Journal of Roentgenology2014;203(5):992‐1000. ">Jang 2014b</a>; <a href="./references#CD010213-bbs2-0027" title="KangKM , LeeJM , ShinCI , BaekJH , KimSH , YoonJH , et al. Added value of diffusion‐weighted imaging to MR cholangiopancreatography with unenhanced MR imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas. Journal of Magnetic Resonance Imaging2013;38(3):555‐63. KimSH , LeeJM , LeeES , BaekJH , KimJH , HanJK , et al. Intraductal papillary mucinous neoplasms of the pancreas: Evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology2015;274(3):723‐33. ">Kim 2015</a>; <a href="./references#CD010213-bbs2-0039" title="OgawaT , HoraguchiJ , FujitaN , NodaY , KobayashiG , ItoK , et al. Diffusion‐weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. Journal of Hepato‐Biliary‐Pancreatic Sciences2014;21(11):801‐8. ">Ogawa 2014</a>). The summary sensitivity and summary specificity for diagnosing high‐grade dysplasia or invasive cancer were 0.69 (95% CI 0.44 to 0.86) and 0.93 (95% CI 0.43 to 1.00), respectively. </p> <p>The results including sensitivities and specificities and post‐test probabilities at median pre‐test probabilities are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising all of the sensitivity and specificity data for the 'cancer (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia)' studies is shown in <a href="#CD010213-fig-0009">Figure 9</a>. </p> <div class="figure" id="CD010213-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot ‐ Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia)." data-id="CD010213-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia). </p> </div> </div> </div> </section> <section id="CD010213-sec-0071"> <h4 class="title">Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia)</h4> <p><b>EUS:</b> We included one study reporting data on 51 participants for this test (<a href="./references#CD010213-bbs2-0030" title="KuboH , ChijiiwaY , AkahoshiK , HamadaS , HaradaN , SumiiT , et al. Intraductal papillary‐mucinous tumors of the pancreas: Differential diagnosis between benign and malignant tumors by endoscopic ultrasonography. American Journal of Gastroenterology2001;96(5):1429‐34. ">Kubo 2001</a>). The sensitivity and specificity for diagnosing invasive cancer were 0.77 (95% CI 0.50 to 0.92) and 0.89 (95% CI 0.76 to 0.96), respectively. </p> <p><b>CT:</b> We included one study reporting data on 46 participants for this test (<a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>). The sensitivity and specificity for diagnosing invasive cancer were 0.50 (95% CI 0.22 to 0.78) and 0.95 (95% CI 0.83 to 0.99), respectively. </p> <p>The results including sensitivities and specificities and post‐test probabilities at median pre‐test probabilities are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising all of the sensitivity and specificity data for the 'cancer (invasive carcinoma) versus precancerous (low‐grade dysplasia)' studies is shown in <a href="#CD010213-fig-0010">Figure 10</a>. </p> <div class="figure" id="CD010213-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia)." data-id="CD010213-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia).</p> </div> </div> </div> </section> <section id="CD010213-sec-0072"> <h4 class="title">Precancerous or cancer (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) </h4> <p><b>CT:</b> Three studies reporting data on 106 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0038" title="OgawaH , ItohS , IkedaM , SuzukiK , NaganawaS . Intraductal papillary mucinous neoplasm of the pancreas: Assessment of the likelihood of invasiveness with multisection CT. Radiology2008;248(3):876‐86. ">Ogawa 2008</a>; <a href="./references#CD010213-bbs2-0042" title="SahaniDV , KadavigereR , BlakeM , CastilloCFD , LauwersGY , HahnPF . Intraductal papillary mucinous neoplasm of pancreas: Multi‐detector row CT with 20 curved reformations ‐ correlation with MRCP. Radiology2006;238(2):560‐9. ">Sahani 2006</a>; <a href="./references#CD010213-bbs2-0049" title="TanL , ZhaoYE , WangDB , WangQB , HuJ , ChenKM , et al. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi‐detector row computed tomography. World Journal of Gastroenterology2009;15(32):4037‐43. ">Tan 2009</a>). The summary sensitivity and summary specificity for diagnosing intermediate‐ or high‐grade dysplasia or invasive cancer were 0.83 (95% CI 0.68 to 0.92) and 0.83 (95% CI 0.64 to 0.93), respectively. </p> <p><b>MRI:</b> Two studies reporting data on 71 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0006" title="ChoiBS , KimTK , KimAY , KimKW , ParkSW , KimPN , et al. Differential diagnosis of benign and malignant intraductal papillary mucinous tumors of the pancreas: MR cholangiopancreatography and MR angiography. Korean Journal of Radiology2003;4(3):157‐62. ">Choi 2003</a>; <a href="./references#CD010213-bbs2-0048" title="TakeshitaK , KutomiK , TakadaK , HaruyamaT , FukushimaJ , AidaR , et al. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: Evaluation of predictive factors by logistic regression analysis. Journal of Computer Assisted Tomography2008;32(2):191‐7. ">Takeshita 2008</a>). The summary sensitivity and specificity for diagnosing intermediate‐ or high‐grade dysplasia or invasive cancer were 0.80 (95% CI 0.58 to 0.92) and 0.81 (95% CI 0.53 to 0.95), respectively. </p> <p>The results including sensitivities and specificities and post‐test probabilities at median pre‐test probabilities are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising all of the sensitivity and specificity data for the 'precancerous or cancer (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia)' studies is shown in <a href="#CD010213-fig-0011">Figure 11</a>. </p> <div class="figure" id="CD010213-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Forest plot ‐ Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia)." data-id="CD010213-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia). </p> </div> </div> </div> </section> <section id="CD010213-sec-0073"> <h4 class="title">Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign </h4> <p><b>EUS:</b> We included one study reporting data on 70 participants for this test (<a href="./references#CD010213-bbs2-0025" title="KamataK , KitanoM , OmotoS , KadosakaK , MiyataT , YamaoK , et al. Contrast‐enhanced harmonic endoscopic ultrasonography for differential diagnosis of pancreatic cysts. Endoscopy2016;48(1):35‐41. ">Kamata 2016a</a>). The sensitivity and specificity for diagnosing intermediate‐ or high‐grade dysplasia or invasive carcinoma were 0.97 (95% CI 0.83 to 0.99) and 0.40 (95% CI 0.26 to 0.55), respectively. </p> <p>The results including sensitivity and specificity and post‐test probability at median pre‐test probability are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. A forest plot summarising the sensitivity and specificity data for the 'precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign' study is shown in <a href="#CD010213-fig-0012">Figure 12</a>. </p> <div class="figure" id="CD010213-fig-0012"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 12</div> </div> <hr class="top"/><img alt="Forest plot of 33 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) or benign ‐ EUS." data-id="CD010213-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG12.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of 33 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) or benign ‐ EUS. </p> </div> </div> </div> </section> <section id="CD010213-sec-0074"> <h4 class="title">Subgroup analyses</h4> <p>We assessed the performance of the tests excluding any studies investigating participants with solid lesions and those in which information for solid and cystic lesions was not reported separately. All of the studies assessing the ability of different imaging modalities to differentiate precancerous versus cancerous lesions regardless of the definitions used by authors for precancer and cancer (Analysis 4 to Analysis 8) included participants with cystic focal pancreatic lesions only, therefore all the results reported are for cystic focal pancreatic lesions only. </p> <p>In the analysis assessing the ability of different imaging modalities to differentiate benign or precancerous versus cancerous lesions, we excluded one study because if did not specify the type (solid or cystic) of lesions for which included participants were investigated (<a href="./references#CD010213-bbs2-0019" title="JafarimehrE , LilienDL , ZibariGB , Shokouh‐AmiriH . Role of 18 f‐fluorodeoxyglucose positron emission tomography in detecting pancreatic lesion. HPB2010;12:412. ">Jafarimehr 2010</a>). However, as this study did not contribute to a meta‐analysis, there were no changes to the analysis. </p> <section id="CD010213-sec-0075"> <h5 class="title">Cancerous versus benign</h5> <p>In the analysis assessing the ability of different imaging modalities to differentiate benign versus cancerous lesions, we excluded eight studies because they did not explicitly include participants with cystic lesions (<a href="./references#CD010213-bbs2-0001" title="BrandB , PfaffT , BinmoellerKF , SriramPV , Fritscher‐RavensA , KnofelWT , et al. Endoscopic ultrasound for differential diagnosis of focal pancreatic lesions, confirmed by surgery. Scandinavian Journal of Gastroenterology2000;35(11):1221‐8. ">Brand 2000</a>; <a href="./references#CD010213-bbs2-0010" title="ErkanM , HerrmannK , DobritzM , SchmidRM , FriessH , SchwaigerM , et al. Comparison of 3'‐deoxy‐3'‐[18f] fluorothymidine positron emission tomography (flt‐pet) and FDG‐PET/CT for the detection and characterization of pancreatic tumors. HPB2012;14:207. ">Erkan 2012</a>; <a href="./references#CD010213-bbs2-0014" title="GrieserC , SteffenIG , GrajewskiL , StelterL , StreitparthF , SchnapauffD , et al. Preoperative multidetector row computed tomography for evaluation and assessment of resection criteria in patients with pancreatic masses. Acta Radiologica2010;51(10):1067‐77. ">Grieser 2010</a>; <a href="./references#CD010213-bbs2-0015" title="HarrisonJL , MillikanKW , PrinzRA , ZaidiS . Endoscopic ultrasound for diagnosis and staging of pancreatic tumors. American Surgeon1999;65(7):659‐64; discussion 664‐5. ">Harrison 1999</a>; <a href="./references#CD010213-bbs2-0016" title="HigashiT , TamakiN , HondaT , TorizukaT , KimuraT , InokumaT , et al. Expression of glucose transporters in human pancreatic tumors compared with increased FDG accumulation in pet study. Journal of Nuclear Medicine1997;38(9):1337‐44. ">Higashi 1997</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>; <a href="./references#CD010213-bbs2-0026" title="KatoT , FukatsuH , ItoK , TadokoroM , OtaT , IkedaM , et al. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: An unsolved problem. European Journal of Nuclear Medicine1995;22(1):32‐9. ">Kato 1995</a>; <a href="./references#CD010213-bbs2-0028" title="KlauM , LemkeA , GrunbergK , SimonD , ReTJ , WenteMN , et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Investigative Radiology2011;46(1):57‐63. ">Klau 2011</a>), and one study that only had one component included (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0003" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Solid</a>). This left two remaining studies, which did not contribute to a meta‐analysis due to the exclusion of the other studies (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>). We therefore performed no meta‐analyses for this group. The new findings for benign versus cancerous lesions are described below. </p> <p><b>EUS‐FNA:</b> We included one study reporting data on 26 participants for this test (<a href="./references#CD010213-bbs2-0002" title="BrandweinSL , FarrellJJ , CentenoBA , BruggeWR . Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointestinal Endoscopy2001;53(7):722‐7. ">Brandwein 2001 ‐ Cystic</a>). The sensitivity and specificity for diagnosing cancer were 0.50 (95% CI 0.19 to 0.81) and 1.00 (95% CI 0.84 to 1.00), respectively. </p> <p><b>PET:</b> We included one study reporting data on 80 participants for this test (<a href="./references#CD010213-bbs2-0018" title="HuSL , YangZY , ZhouZR , YuXJ , PingB , ZhangYJ . Role of SUV(max) obtained by 18f‐FDG PET/CT in patients with a solitary pancreatic lesion: Predicting malignant potential and proliferation. Nuclear Medicine Communications2013;34(6):533‐9. ">Hu 2013</a>). The sensitivity and specificity for diagnosing cancer were 0.96 (95% CI 0.87 to 0.99) and 0.62 (95% CI 0.43 to 0.78), respectively. </p> <p>A forest plot summarising all the sensitivity and specificity data for the cystic subgroup analysis of 'cancerous versus benign lesion' studies is shown in <a href="#CD010213-fig-0013">Figure 13</a>. </p> <div class="figure" id="CD010213-fig-0013"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 13</div> </div> <hr class="top"/><img alt="Forest plot ‐ Cystic lesion subgroup analysis: Cancerous versus benign." data-id="CD010213-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG13.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Cystic lesion subgroup analysis: Cancerous versus benign.</p> </div> </div> </div> </section> <section id="CD010213-sec-0076"> <h5 class="title">Precancerous or cancerous versus benign</h5> <p>In the analysis assessing the ability of different imaging modalities to differentiate precancerous or cancerous versus benign lesions, we excluded a component of one study because the participants had solid pancreatic lesions (<a href="./references#CD010213-bbs2-0012" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Solid</a>). We therefore re‐performed the meta‐analysis for precancerous or cancerous versus benign lesions ‐ EUS‐FNA without these data. The remaining tests for this target condition did not have any studies excluded and were therefore not redone. The new findings are described below. </p> <p><b>EUS‐FNA:</b> Two studies reporting data on 34 participants were included for this test, allowing meta‐analysis to be performed (<a href="./references#CD010213-bbs2-0011" title="FischerCP , FahyBN , AloiaTA , RaijmanI , BarrosoAO , SchwarzPJ , et al. Fine needle aspiration cytology from pancreatic cysts ‐ limited utility in surgical decision making. Gastroenterology2009;136(5 Suppl 1):A886. ">Fischer 2009 ‐ Cystic</a>; <a href="./references#CD010213-bbs2-0045" title="SedlackR , AffiA , Vazquez‐SequeirosE , NortonID , ClainJE , WiersemaMJ . Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointestinal Endoscopy2002;56(4):543‐7. ">Sedlack 2002</a>). The summary sensitivity and summary specificity for diagnosing precancer or cancer were 0.43 (95% CI 0.19 to 0.71) and 1.00 (95% CI 0.74 to 1.00), respectively. </p> <p>A forest plot summarising the sensitivity and specificity data for the cystic subgroup analysis of 'precancerous or cancerous versus benign lesion' study is shown in <a href="#CD010213-fig-0014">Figure 14</a>. </p> <div class="figure" id="CD010213-fig-0014"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 14</div> </div> <hr class="top"/><img alt="Forest plot ‐ Cystic lesion subgroup analysis: Precancerous or cancerous versus benign ‐ EUS‐FNA." data-id="CD010213-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG14.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot ‐ Cystic lesion subgroup analysis: Precancerous or cancerous versus benign ‐ EUS‐FNA. </p> </div> </div> </div> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010213-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010213-sec-0077"></div> <section id="CD010213-sec-0078"> <h3 class="title" id="CD010213-sec-0078">Summary of main results</h3> <p>The results are summarised in <a href="./full#CD010213-tbl-0001">summary of findings Table</a>. </p> <p>We included 54 studies involving a total of 3196 participants that evaluated the diagnostic accuracy of various imaging modalities (EUS, EUS‐FNA, PET, CT, and MRI) for characterising focal pancreatic lesions. We identified eight different target conditions in these studies, with the studies using imaging modalities to differentiate: cancerous versus benign or precancerous lesions; cancerous versus benign lesions; precancerous or cancerous lesions versus benign lesions; cancerous (invasive carcinoma) versus precancerous (dysplasia) lesions; cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) lesions; cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) lesions; precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) lesions; and precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign lesions. The wide variety of tumour types that constituted benign and cancerous lesions within the studies meant that only a few meaningful meta‐analyses could be performed. None of the comparisons in which single studies were included were of sufficiently high methodological quality to warrant highlighting of the results. </p> <p>For differentiation of cancerous lesions from benign or precancerous lesions, only single studies were included and therefore meta‐analysis was not performed. Overall, EUS‐FNA (cytology) had a sensitivity of 0.79 (95% CI 0.60 to 0.91) and specificity of 1.00 (95% CI 0.85 to 1.00); EUS‐FNA (CEA &gt; 500 ng/mL) had a sensitivity of 0.93 (95% CI 0.70 to 0.99) and specificity of 0.33 (95% CI 0.12 to 0.65); and PET had a sensitivity of 0.85 (95% CI 0.73 to 0.92) and specificity of 0.91 (95% CI 0.72 to 0.97). </p> <p>The second analysis, of studies differentiating cancerous versus benign lesions, provided three tests in which meta‐analysis could be performed, however the data were sparse: one of these tests contained three studies, and the remaining two tests contained two studies, meaning the meta‐analysis was of limited value. There was little difference in the diagnostic test accuracy between the imaging techniques. EUS‐FNA achieved very high specificity (of 1.00, i.e. no false negatives) but modest sensitivity (0.79; 95% CI 0.07 to 1.00). A high specificity of EUS‐FNA can be expected, since this involves physically sampling the lesion. However, the modest sensitivity may reflect that the sampling methods were inadequate. Additional guidance such as identifying the location most likely to yield the correct results or additional guidance using optical endoscopy techniques such as confocal laser microendoscopy may overcome this problem and improve the sensitivity of EUS (<a href="./references#CD010213-bbs2-0942" title="GiovanniniM , CaillolF , PoizatF , BoriesE , PesentiC , MongesG , et al. Feasibility of intratumoral confocal microscopy under endoscopic ultrasound guidance. Endoscopic Ultrasound2012;1(2):80‐3. ">Giovannini 2012</a>), but there are major challenges, such as knowing the area within the lesion that is being examined by confocal laser microendoscopy, that must be addressed before such methods can be used routinely. </p> <p>The third analysis, of studies differentiating precancerous or cancerous and benign lesions, only provided one test (EUS‐FNA) for which meta‐analysis was performed. The results were unreliable due to significant heterogeneity in the results between the studies. </p> <p>The fourth analysis, of studies differentiating cancerous (invasive carcinoma) versus precancerous (dysplasia) lesions, provided three tests in which meta‐analysis was performed, with one test containing five studies (EUS), one test containing three studies (EUS‐FNA), and the third test containing six studies (CT). All five of the tests included in the analysis had a similar level of accuracy according to their respective ROC curves. EUS and CT showed the highest (and similar) accuracy estimates (EUS = sensitivity 0.78 and specificity 0.91; CT = sensitivity 0.72 and specificity 0.92) and included the largest number of studies (five and six, respectively) among all comparisons. </p> <p>The fifth analysis, of studies differentiating cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) lesions, provided six tests in which meta‐analysis was performed, with two tests containing four studies (EUS and PET SUVmax 2 to 2.5), one test containing two studies (EUS‐FNA), three tests containing three studies (EUS‐FNA &gt; 200, CT, and MRI), and the remaining two tests providing single studies. PET performed with the highest accuracy (sensitivity 0.90 (95% CI 0.79 to 0.96) and specificity 0.94 (95% CI 0.81 to 0.99)). </p> <p>The sixth analysis, of studies differentiating cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) lesions, provided no tests in which meta‐analysis was performed. </p> <p>The seventh analysis, of studies differentiating precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) lesions, provided two tests in which meta‐analysis was performed. The meta‐analysis results for CT (sensitivity 0.83 (95% CI 0.68 to 0.92) and specificity 0.83 (95% CI 0.64 to 0.93)) were similar to those of MRI (sensitivity 0.80 (95% CI 0.58 to 0.92) and specificity 0.81 (95% CI 0.53 to 0.95)), however lack of significant data means little can be inferred from this. </p> <p>The eighth analysis, of studies differentiating precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign lesions, provided no tests in which meta‐analysis was performed. </p> <p>We performed a subgroup analysis to investigate the performance of imaging modalities for cystic pancreatic lesions. This only resulted in alterations to the 'cancerous versus benign or precancerous', 'cancerous versus benign', and 'precancerous or cancerous versus benign' groups, however when re‐performed in these groups, the analysis did not result in any significant changes. </p> <p>Overall, none of the tests assessed had sufficient overall diagnostic accuracy to be considered a definitive diagnostic modality. High sensitivity of the test is required so that precancer or cancer is not missed. High specificity is required to avoid major surgery. Sensitivity and specificity in excess of 90% are required to recommend the particular modality over other modalities. Only PET in differentiating precancerous (low‐ or intermediate‐grade dysplasia) versus cancer (high‐grade dysplasia or invasive carcinoma) approaches this level of accuracy. Overall, modalities other than EUS‐FNA had moderate to high sensitivity but moderate specificity, while EUS‐FNA had high specificity with moderate sensitivity in distinguishing the nature of focal pancreatic lesions. </p> </section> <section id="CD010213-sec-0079"> <h3 class="title" id="CD010213-sec-0079">Strengths and weaknesses of the review</h3> <p>We conducted a thorough literature search and included full‐text publications and abstracts without any language restrictions. Two review authors independently identified and extracted data from the studies, potentially reducing the chance of error that would be associated with one person performing the data extraction. We used strict reference standards that are likely to diagnose the target condition with a high degree of accuracy. These were the major strengths of the review. </p> <p>We included EUS‐FNA as part of the review. Strictly speaking, EUS‐FNA cannot be considered an imaging modality since it uses cytology criteria or levels of tumour markers in the aspirate rather than imaging features to make the diagnosis. We had mentioned at the protocol stage that we would include EUS‐FNA in this review, as the searches for EUS return EUS‐FNA as well and because EUS‐FNA along with the imaging modalities included in this review are the most widely used tests for characterising focal pancreatic lesions. Our review provides the most important information about the tests performed to characterise focal lesions in one location and hence is probably more useful for clinicians, who would otherwise have to search for another review for information on EUS‐FNA. </p> <p>The major limitation in the review process was the diverse nature of the collected data, with a wide variety of definitions of benign, precancerous, and cancerous lesions. This limited the possible analysis of the data and the conclusions that could be made from our analyses. While some authors defined precancerous lesions as lesions with low‐ and intermediate‐grade dysplasia, others defined it as low‐grade dysplasia only, while yet others considered any form of dysplasia as precancerous lesions. In the comparison 'cancer versus benign', it is unclear how the study authors dealt with precancerous lesions, that is whether they included precancerous lesions in the 'cancer' group or the 'benign' group, or whether they simply excluded them, consequently undermining any conclusions that could be made for this comparison. </p> <p>We could not perform a bivariate random‐effects model that takes correlation between sensitivity and specificity into account and were unable to compare the diagnostic test accuracy of index tests using formal statistical methods due to the sparseness of data for each comparison. As a result, we performed the analysis using simpler models suggested by <a href="./references#CD010213-bbs2-0978" title="TakwoingiY , GuoB , RileyRD , DeeksJJ . Performance of methods for meta‐analysis of diagnostic test accuracy with few studies or sparse data. Statistical methods in medical research 2015 Jun 26 [Epub ahead of print]. [DOI: 10.1177/0962280215592269] ">Takwoingi 2015</a> and colleagues. We reported the model with the lowest ‐2 log likelihood and also visualised the forest plots and ROC plots in deciding the model to be reported. The confidence intervals were extremely wide for the following analyses: benign versus cancer: CT; benign versus cancer: EUS‐FNA; benign versus precancer or cancer: EUS‐FNA; and precancer (low‐ or intermediate‐grade dysplasia) versus cancer (high‐grade dysplasia or invasive carcinoma): CT. While fixed‐effect model provided narrower confidence intervals for some of the above analyses, such models were inappropriate for these data because of the poor overlap of confidence intervals on the forest plot. This observation (i.e. that fixed‐effect models were not appropriate) was supported by the ‐2 log likelihoods, which were higher for the univariate fixed‐effect model than those of the models presented. The alternative was not to perform a meta‐analysis at all, which is even more difficult to interpret. At least the current results allowed us to interpret that the sensitivity or specificity or both could not be estimated reliably. There was reasonable overlap of confidence intervals in the other meta‐analyses performed. With regard to the tests for which meta‐analysis could not be performed, the diagnostic test accuracy from single studies needs confirmation by other studies to assess whether the results are reproducible. Hence, we are unable to arrive at any major conclusions based on information by a single study. </p> <p>A high proportion of studies were at high risk of bias and with high concern regarding applicability in all four domains of the QUADAS‐2 tool. This makes the validity of the results questionable. Of particular concern was the type of people who underwent these tests. Because of the strict but appropriate reference standard, all of the participants in all of the studies included in this review except <a href="./references#CD010213-bbs2-0005" title="CherianPT , MohanP , DouiriA , TaniereP , HejmadiRK , MahonBS . Role of endoscopic ultrasound‐guided fine‐needle aspiration in the diagnosis of solid pancreatic and peripancreatic lesions: Is onsite cytopathology necessary?. HPB2010;12(6):389‐95. ">Cherian 2010</a> underwent surgical resection. This suggested that the surgeons thought that these participants had high probability of having high‐grade dysplasia or cancer, either because of the results of this test or other tests performed alongside the index tests. Since most of the studies were retrospective studies, if participants were operated on on the basis of the index test, and only participants who underwent surgery were included, participants with negative index tests but who had cancer would have been excluded inappropriately. This would have resulted in overestimation of sensitivity. The studies did not report the proportion of people in whom the different tests were feasible. This is particularly important for EUS and EUS‐FNA, since the participants may have been selected to undergo EUS or EUS‐FNA based on the proximity to the stomach or duodenum. This increases the concern regarding applicability. The studies did not report the complications associated with the index test. While this is unlikely to influence the diagnostic accuracy of the index test, it may have implications in determining the balance of benefits and harms in choosing a test. </p> <p>Another limitation of this review was that we have included sensitivity‐maximising diagnostic filters for searching MEDLINE and Embase databases (<a href="./references#CD010213-bbs2-0946" title="HaynesRB , WilczynskiNL . Optimal search strategies for retrieving scientifically strong studies of diagnosis from MEDLINE: Analytical survey. BMJ2004;328(7447):1040. ">Haynes 2004</a>; <a href="./references#CD010213-bbs2-0984" title="WilczynskiNL , HaynesRB . Embase search strategies for identifying methodologically sound diagnostic studies for use by clinicians and researchers. BMC Medicine2005;3(1):1‐6. ">Wilczynski 2005</a>), and also used terms to limit the searches in Science Citation Index. We did this because the original searches without the filters retrieved more than 60,000 references. We had to balance the possibility of missing some studies against the risk of not being able to complete the review. We decided that it is useful to have evidence from major studies rather than having no information at all. However, it must be noted that the diagnostic filters we used have a sensitivity of 98.6% for MEDLINE and 100% for Embase. Consequently, the chances that we missed some relevant diagnostic studies are extremely low. This was further reduced by performing a 'related search' and 'citing reference search', in which we found no studies that could be included in this review. </p> <p>We identified six other systematic reviews on the topics included in this systematic review (<a href="./references#CD010213-bbs2-0926" title="BanafeaO , MghangaFP , ZhaoJ , ZhaoR , ZhuL . Endoscopic ultrasonography with fine‐needle aspiration for histological diagnosis of solid pancreatic masses: a meta‐analysis of diagnostic accuracy studies. BMC Gastroenterology2016;16:108. [PUBMED: 27580856] ">Banafea 2016</a>; <a href="./references#CD010213-bbs2-0930" title="ChenJ , YangR , LuY , XiaY , ZhouH . Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration for solid pancreatic lesion: a systematic review. Journal of Cancer Research and Clinical Oncology2012;138(9):1433‐41. ">Chen 2012</a>; <a href="./references#CD010213-bbs2-0939" title="FuccioL , HassanC , LaterzaL , CorrealeL , PaganoN , BocusP , et al. The role of K‐ras gene mutation analysis in EUS‐guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta‐analysis of prospective studies. Gastrointestinal Endoscopy2013;78(4):596‐608. ">Fuccio 2013</a>; <a href="./references#CD010213-bbs2-0941" title="GillisA , CipolloneI , CousinsG , ConlonK . Does EUS‐FNA molecular analysis carry additional value when compared to cytology in the diagnosis of pancreatic cystic neoplasm? A systematic review. HPB2015;17(5):377‐86. ">Gillis 2015</a>; <a href="./references#CD010213-bbs2-0947" title="HewittMJ , McPhailMJ , PossamaiL , DharA , VlavianosP , MonahanKJ . EUS‐guided FNA for diagnosis of solid pancreatic neoplasms: a meta‐analysis. Gastrointestinal Endoscopy2012;75(2):319‐31. ">Hewitt 2012</a>; <a href="./references#CD010213-bbs2-0957" title="MeiM , NiJ , LiuD , JinP , SunL . EUS elastography for diagnosis of solid pancreatic masses: a meta‐analysis. Gastrointestinal Endoscopy2013;77(4):578‐89. ">Mei 2013</a>). These included the role of EUS‐FNA (cytology), K‐ras gene mutation analysis of FNA aspirate, and EUS elastography in focal pancreatic lesions. The diagnostic test accuracy in four of the studies showed that EUS cytology and K‐ras gene mutation analysis of FNA aspirate had a reasonably high sensitivity (0.80 to 0.86) and very high specificity (96% to 98%) in solid pancreatic lesions (<a href="./references#CD010213-bbs2-0926" title="BanafeaO , MghangaFP , ZhaoJ , ZhaoR , ZhuL . Endoscopic ultrasonography with fine‐needle aspiration for histological diagnosis of solid pancreatic masses: a meta‐analysis of diagnostic accuracy studies. BMC Gastroenterology2016;16:108. [PUBMED: 27580856] ">Banafea 2016</a>; <a href="./references#CD010213-bbs2-0930" title="ChenJ , YangR , LuY , XiaY , ZhouH . Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration for solid pancreatic lesion: a systematic review. Journal of Cancer Research and Clinical Oncology2012;138(9):1433‐41. ">Chen 2012</a>; <a href="./references#CD010213-bbs2-0939" title="FuccioL , HassanC , LaterzaL , CorrealeL , PaganoN , BocusP , et al. The role of K‐ras gene mutation analysis in EUS‐guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta‐analysis of prospective studies. Gastrointestinal Endoscopy2013;78(4):596‐608. ">Fuccio 2013</a>; <a href="./references#CD010213-bbs2-0947" title="HewittMJ , McPhailMJ , PossamaiL , DharA , VlavianosP , MonahanKJ . EUS‐guided FNA for diagnosis of solid pancreatic neoplasms: a meta‐analysis. Gastrointestinal Endoscopy2012;75(2):319‐31. ">Hewitt 2012</a>). These studies accepted cytology and clinical follow‐up (without specifying the exact nature of acceptable clinical follow‐up) in addition to histopathology as reference standards (<a href="./references#CD010213-bbs2-0930" title="ChenJ , YangR , LuY , XiaY , ZhouH . Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration for solid pancreatic lesion: a systematic review. Journal of Cancer Research and Clinical Oncology2012;138(9):1433‐41. ">Chen 2012</a>; <a href="./references#CD010213-bbs2-0939" title="FuccioL , HassanC , LaterzaL , CorrealeL , PaganoN , BocusP , et al. The role of K‐ras gene mutation analysis in EUS‐guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta‐analysis of prospective studies. Gastrointestinal Endoscopy2013;78(4):596‐608. ">Fuccio 2013</a>; <a href="./references#CD010213-bbs2-0947" title="HewittMJ , McPhailMJ , PossamaiL , DharA , VlavianosP , MonahanKJ . EUS‐guided FNA for diagnosis of solid pancreatic neoplasms: a meta‐analysis. Gastrointestinal Endoscopy2012;75(2):319‐31. ">Hewitt 2012</a>). It is likely that this methodological difference was responsible for the major differences between our observations and these systematic reviews. In addition, these systematic reviews restricted participants to those with solid pancreatic lesions (<a href="./references#CD010213-bbs2-0926" title="BanafeaO , MghangaFP , ZhaoJ , ZhaoR , ZhuL . Endoscopic ultrasonography with fine‐needle aspiration for histological diagnosis of solid pancreatic masses: a meta‐analysis of diagnostic accuracy studies. BMC Gastroenterology2016;16:108. [PUBMED: 27580856] ">Banafea 2016</a>; <a href="./references#CD010213-bbs2-0930" title="ChenJ , YangR , LuY , XiaY , ZhouH . Diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration for solid pancreatic lesion: a systematic review. Journal of Cancer Research and Clinical Oncology2012;138(9):1433‐41. ">Chen 2012</a>; <a href="./references#CD010213-bbs2-0939" title="FuccioL , HassanC , LaterzaL , CorrealeL , PaganoN , BocusP , et al. The role of K‐ras gene mutation analysis in EUS‐guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta‐analysis of prospective studies. Gastrointestinal Endoscopy2013;78(4):596‐608. ">Fuccio 2013</a>; <a href="./references#CD010213-bbs2-0947" title="HewittMJ , McPhailMJ , PossamaiL , DharA , VlavianosP , MonahanKJ . EUS‐guided FNA for diagnosis of solid pancreatic neoplasms: a meta‐analysis. Gastrointestinal Endoscopy2012;75(2):319‐31. ">Hewitt 2012</a>), which could be another explanation for the differences between our observations and these systematic reviews. One systematic review evaluated EUS elastography in focal pancreatic lesions and reported a high sensitivity of 0.95 and a specificity of 0.67 (<a href="./references#CD010213-bbs2-0957" title="MeiM , NiJ , LiuD , JinP , SunL . EUS elastography for diagnosis of solid pancreatic masses: a meta‐analysis. Gastrointestinal Endoscopy2013;77(4):578‐89. ">Mei 2013</a>). We did not identify any study evaluating EUS elastography that met our inclusion criteria with respect to our reference standard, therefore we are unable to comment on the observation by <a href="./references#CD010213-bbs2-0957" title="MeiM , NiJ , LiuD , JinP , SunL . EUS elastography for diagnosis of solid pancreatic masses: a meta‐analysis. Gastrointestinal Endoscopy2013;77(4):578‐89. ">Mei 2013</a>. The last systematic review evaluated the role of EUS‐FNA and EUS‐FNA molecular analysis (i.e. check for abnormal genes) in people with cystic pancreatic lesions. The authors found poor sensitivity and high specificity of EUS‐FNA, which is similar to our findings (<a href="./references#CD010213-bbs2-0941" title="GillisA , CipolloneI , CousinsG , ConlonK . Does EUS‐FNA molecular analysis carry additional value when compared to cytology in the diagnosis of pancreatic cystic neoplasm? A systematic review. HPB2015;17(5):377‐86. ">Gillis 2015</a>). </p> </section> <section id="CD010213-sec-0080"> <h3 class="title" id="CD010213-sec-0080">Applicability of findings to the review question</h3> <p>All studies had high applicability concerns, making the applicability of findings to the target patient population of all incidental lesions questionable. The findings are applicable only for people who are suspected to be at high risk of high‐grade dysplasia or cancer. The review question was to find out the diagnostic accuracy of these index tests in people with focal pancreatic lesions, usually detected incidentally. However, all of the studies that met the inclusion criteria for this review used surgical excision as the reference standard, suggesting that the surgeons considered these patients to have a high risk of malignancy based on the results of the index tests or any additional tests. In terms of current availability of these tests, CT scan and MRI are likely to be available in most secondary centres. EUS is likely to be available in limited secondary centres and most tertiary centres that treat pancreatic lesions. PET is likely to be available only in limited tertiary centres, although the tertiary centres are likely to have access to a PET scan. However, based on the observations in this review, there do not appear to be any major differences between the different imaging modalities. The improved sensitivity of EUS‐FNA compared to other imaging modalities is compensated by a corresponding decrease in sensitivity, consequently there do not appear to be major advantages to using EUS for characterising focal pancreatic lesions compared to other non‐invasive methodologies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010213-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Clinical pathway.Abbreviations:Ca 19‐9: carbohydrate antigen 19‐9  CT: computed tomography  EUS: endoscopic ultrasound  MRI: magnetic resonance imaging  PET: positron emission tomography" data-id="CD010213-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Clinical pathway.</p> <p>Abbreviations:</p> <p>Ca 19‐9: carbohydrate antigen 19‐9<br/> CT: computed tomography<br/> EUS: endoscopic ultrasound<br/> MRI: magnetic resonance imaging<br/> PET: positron emission tomography </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD010213-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies." data-id="CD010213-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study." data-id="CD010213-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Cancerous versus benign or precancerous." data-id="CD010213-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot ‐ Cancerous versus benign or precancerous.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Cancerous versus benign." data-id="CD010213-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot ‐ Cancerous versus benign.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Precancerous or cancerous versus benign." data-id="CD010213-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot ‐ Precancerous or cancerous versus benign.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (dysplasia)." data-id="CD010213-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (dysplasia).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia)." data-id="CD010213-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot ‐ Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia)." data-id="CD010213-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Forest plot ‐ Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia)." data-id="CD010213-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Forest plot ‐ Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG12.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of 33 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) or benign ‐ EUS." data-id="CD010213-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 12</div> <div class="figure-caption"> <p>Forest plot of 33 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) or benign ‐ EUS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG13.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Cystic lesion subgroup analysis: Cancerous versus benign." data-id="CD010213-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 13</div> <div class="figure-caption"> <p>Forest plot ‐ Cystic lesion subgroup analysis: Cancerous versus benign.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-AFig-FIG14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-AFig-FIG14.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot ‐ Cystic lesion subgroup analysis: Precancerous or cancerous versus benign ‐ EUS‐FNA." data-id="CD010213-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 14</div> <div class="figure-caption"> <p>Forest plot ‐ Cystic lesion subgroup analysis: Precancerous or cancerous versus benign ‐ EUS‐FNA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-AFig-FIG14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-001" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-001.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign or precancerous ‐ EUS‐FNA (cytology)." data-id="CD010213-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-001.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 1</div> <div class="figure-caption"> <p>Cancerous versus benign or precancerous ‐ EUS‐FNA (cytology).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-001.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-002" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-002.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign or precancerous ‐ EUS‐FNA (CEA &gt; 500 ng/mL)." data-id="CD010213-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-002.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 2</div> <div class="figure-caption"> <p>Cancerous versus benign or precancerous ‐ EUS‐FNA (CEA &gt; 500 ng/mL).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-002.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-003" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-003.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign or precancerous ‐ PET." data-id="CD010213-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-003.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 3</div> <div class="figure-caption"> <p>Cancerous versus benign or precancerous ‐ PET.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-003.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-004" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-004.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign ‐ EUS." data-id="CD010213-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-004.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 4</div> <div class="figure-caption"> <p>Cancerous versus benign ‐ EUS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-004.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-005" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-005.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign ‐ EUS‐FNA." data-id="CD010213-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-005.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 5</div> <div class="figure-caption"> <p>Cancerous versus benign ‐ EUS‐FNA.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-005.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-006" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-006.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign ‐ PET." data-id="CD010213-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-006.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 6</div> <div class="figure-caption"> <p>Cancerous versus benign ‐ PET.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-006.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-007" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-007.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign ‐ PET (SUVmax &gt; 3.5)." data-id="CD010213-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-007.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 7</div> <div class="figure-caption"> <p>Cancerous versus benign ‐ PET (SUVmax &gt; 3.5).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-007.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-008" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-008.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign ‐ CT." data-id="CD010213-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-008.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 8</div> <div class="figure-caption"> <p>Cancerous versus benign ‐ CT.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-008.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-009" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-009.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous versus benign ‐ MRI." data-id="CD010213-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-009.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 9</div> <div class="figure-caption"> <p>Cancerous versus benign ‐ MRI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-009.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-010" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-010.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous versus benign ‐ EUS." data-id="CD010213-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-010.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 10</div> <div class="figure-caption"> <p>Precancerous or cancerous versus benign ‐ EUS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-010.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-011" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-011.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous versus benign ‐ EUS‐FNA." data-id="CD010213-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-011.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 11</div> <div class="figure-caption"> <p>Precancerous or cancerous versus benign ‐ EUS‐FNA.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-011.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-012" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-012.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous versus benign ‐ EUS‐FNA (CEA &gt; 50 ng/mL)." data-id="CD010213-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-012.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 12</div> <div class="figure-caption"> <p>Precancerous or cancerous versus benign ‐ EUS‐FNA (CEA &gt; 50 ng/mL).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-012.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-013" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-013.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous versus benign ‐ PET (SUVmax &gt; 2.4)." data-id="CD010213-fig-0027" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-013.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 13</div> <div class="figure-caption"> <p>Precancerous or cancerous versus benign ‐ PET (SUVmax &gt; 2.4).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-013.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-014" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-014.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous versus benign ‐ CT." data-id="CD010213-fig-0028" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-014.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 14</div> <div class="figure-caption"> <p>Precancerous or cancerous versus benign ‐ CT.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-014.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-015" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-015.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous versus benign ‐ MRI." data-id="CD010213-fig-0029" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-015.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 15</div> <div class="figure-caption"> <p>Precancerous or cancerous versus benign ‐ MRI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-015.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-016" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-016.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS." data-id="CD010213-fig-0030" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-016.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 16</div> <div class="figure-caption"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-016.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-017" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-017.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS‐FNA." data-id="CD010213-fig-0031" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-017.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 17</div> <div class="figure-caption"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS‐FNA.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-017.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-018" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-018.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS‐FNA (CEA &gt; 200 ng/mL)." data-id="CD010213-fig-0032" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-018.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 18</div> <div class="figure-caption"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS‐FNA (CEA &gt; 200 ng/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-018.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-019" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-019.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ CT." data-id="CD010213-fig-0033" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-019.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 19</div> <div class="figure-caption"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ CT.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-019.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-020" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-020.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ MRI." data-id="CD010213-fig-0034" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-020.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 20</div> <div class="figure-caption"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ MRI.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-020.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-021" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-021.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS." data-id="CD010213-fig-0035" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-021.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 21</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-021.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-022" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-022.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA." data-id="CD010213-fig-0036" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-022.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 22</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-022.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-023" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-023.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CEA &gt; 200 ng/mL)." data-id="CD010213-fig-0037" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-023.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 23</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CEA &gt; 200 ng/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-023.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-024" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-024.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CA 19‐9 &gt; 1000 U/mL)." data-id="CD010213-fig-0038" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-024.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 24</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CA 19‐9 &gt; 1000 U/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-024.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-025" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-025.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CEA &gt; 692.8 ng/mL)." data-id="CD010213-fig-0039" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-025.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 25</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CEA &gt; 692.8 ng/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-025.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-026" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-026.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ PET (SUVmax 2 to 2.5)." data-id="CD010213-fig-0040" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-026.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 26</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ PET (SUVmax 2 to 2.5). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-026.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-027" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-027.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ CT." data-id="CD010213-fig-0041" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-027.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 27</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ CT. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-027.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-028" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-028.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ MRI." data-id="CD010213-fig-0042" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-028.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 28</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ MRI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-028.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-029" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-029.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ EUS." data-id="CD010213-fig-0043" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-029.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 29</div> <div class="figure-caption"> <p>Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ EUS.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-029.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-030" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-030.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ CT." data-id="CD010213-fig-0044" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-030.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 30</div> <div class="figure-caption"> <p>Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ CT.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-030.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-031" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-031.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ CT." data-id="CD010213-fig-0045" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-031.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 31</div> <div class="figure-caption"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ CT. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-031.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-032" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-032.xxx" target="_blank"><b></b></a></p> </div><img alt="Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ MRI." data-id="CD010213-fig-0046" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-032.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 32</div> <div class="figure-caption"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ MRI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-032.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-033" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-033.xxx" target="_blank"><b></b></a></p> </div><img alt="Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) or benign ‐ EUS." data-id="CD010213-fig-0047" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-033.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 33</div> <div class="figure-caption"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) or benign ‐ EUS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-033.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-034" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-034.xxx" target="_blank"><b></b></a></p> </div><img alt="Cystic lesion subgroup analysis ‐ Cancerous versus benign ‐ EUS‐FNA." data-id="CD010213-fig-0048" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-034.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 34</div> <div class="figure-caption"> <p>Cystic lesion subgroup analysis ‐ Cancerous versus benign ‐ EUS‐FNA.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-034.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-035" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-035.xxx" target="_blank"><b></b></a></p> </div><img alt="Cystic lesion subgroup analysis ‐ Cancerous versus benign ‐ PET." data-id="CD010213-fig-0049" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-035.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 35</div> <div class="figure-caption"> <p>Cystic lesion subgroup analysis ‐ Cancerous versus benign ‐ PET.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-035.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010213-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/urn:x-wiley:14651858:media:CD010213:CD010213-TST-036" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_t/tCD010213-TST-036.xxx" target="_blank"><b></b></a></p> </div><img alt="Cystic lesion subgroup analysis ‐ Precancerous or cancerous versus benign ‐ EUS‐FNA." data-id="CD010213-fig-0050" src="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-036.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 36</div> <div class="figure-caption"> <p>Cystic lesion subgroup analysis ‐ Precancerous or cancerous versus benign ‐ EUS‐FNA.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/media/CDSR/CD010213/image_n/nCD010213-TST-036.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010213-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Imaging modalities for characterising focal pancreatic lesions</span></div> <tbody> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Name of test</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Number of studies (number of participants)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Sensitivity (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Specificity (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Post‐test probability of positive test* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Post‐test probability of negative test* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Number of false positives per 100 positive index test results (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Number of false negatives per 100 negative index test results (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Risk of bias</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Applicability concerns</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b> Uncertainty (due to inconsistency or inability to assess inconsistency, and random errors because of overall small sample size)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="11" rowspan="1" valign=""> <p><b> Cancerous versus benign or precancerous (median pre‐test probability: 63%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (45)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.79</b> (0.60 to 0.91) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1.00</b> (0.85 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>98%</b> (79% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>26%</b> (14% to 43%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>2</b> (0 to 21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>26</b> (14 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 500 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (24)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.70 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.33</b> (0.12 to 0.65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>70%</b> (59% to 79%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25%</b> (4% to 73%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>30</b> (21 to 41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (4 to 73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (criteria unspecified) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (76)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.85</b> (0.73 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.72 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>94%</b> (81% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21%</b> (12% to 34%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (2 to 19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21</b> (12 to 34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous versus benign (median pre‐test probability: 70%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (133)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.95</b> (0.84 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.53</b> (0.31 to 0.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>82%</b> (74% to 88%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18%</b> (6% to 45%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18</b> (12 to 26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>18</b> (6 to 45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (147)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.79</b> (0.07 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1.00</b> (0.91 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>99%</b> (90% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32%</b> (2% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 (0 to 9)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32</b> (2 to 92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (criteria unspecified) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.80 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.65</b> (0.39 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>86%</b> (75% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22%</b> (9% to 44%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>14</b> (8 to 25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> (9 to 44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (SUVmax &gt; 3.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (80)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.96</b> (0.87 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.62</b> (0.43 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>85%</b> (78% to 90%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12%</b> (3% to 36%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15</b> (10 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12</b> (3 to 36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (123)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.98</b> (0.00 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.76</b> (0.02 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>90%</b> (17% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6%</b> (0% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10</b> (0 to 83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (0 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (29)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.80</b> (0.58 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.89</b> (0.57 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>94%</b> (72% to 99%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>34%</b> (17% to 56%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (1 to 28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>34</b> (17 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Precancerous or cancerous versus benign (median pre‐test probability: 71%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (34)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.74 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.60</b> (0.31 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>85%</b> (72% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25%</b> (7% to 58%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15</b> (8 to 28) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (7 to 58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (52)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.73</b> (0.01 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.94</b> (0.15 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>97%</b> (25% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>41%</b> (1% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>3</b> (0 to 75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>41</b> (1 to 98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 50 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (11)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.29</b> (0.08 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.25</b> (0.05 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>48%</b> (20% to 77%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>87%</b> (54% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>52</b> (23 to 80) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>87</b> (54 to 98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (SUVmax 2.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (32)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.94</b> (0.74 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.69 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>97%</b> (83% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13%</b> (2% to 49%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>3</b> (0 to 17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13</b> (2 to 49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (48)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.62</b> (0.45 to 0.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.64</b> (0.39 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81%</b> (66% to 90%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>59%</b> (44% to 72%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19</b> (10 to 34) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>59</b> (44 to 72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (27)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.69 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.85</b> (0.58 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>94%</b> (80% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>17%</b> (3% to 58%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (2 to 20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>17</b> (3 to 58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous (invasive carcinoma) versus precancerous (dysplasia) (median pre‐test probability: 27%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 (156)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.78</b> (0.45 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.61 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>75%</b> (37% to 94%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8%</b> (3% to 22%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (6 to 63) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8</b> (3 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (158)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.66</b> (0.03 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.73 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>75%</b> (29% to 95%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12%</b> (1% to 69%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>25</b> (5 to 71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>12</b> (1 to 69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (41)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>1.00</b> (0.57 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.64</b> (0.48 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>51%</b> (40% to 61%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Not estimable</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>49</b> (39 to 60) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Not estimable</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 (326)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.72</b> (0.50 to 0.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.92</b> (0.81 to 0.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>78%</b> (57% to 91%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10%</b> (5% to 18%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>22</b> (9 to 43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10</b> (5 to 18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (32)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.75</b> (0.30 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.77 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>80%</b> (48% to 94%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>9%</b> (2% to 35%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>20</b> (6 to 52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>9</b> (2 to 35) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) (median pre‐test probability: 45%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (196)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.86</b> (0.74 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.83 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>89%</b> (80% to 94%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11%</b> (7% to 19%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (6 to 20) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (7 to 19) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (310)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.47</b> (0.24 to 0.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.91</b> (0.32 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>81%</b> (19% to 99%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32%</b> (22% to 45%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19</b> (1 to 81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>32</b> (22 to 45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (160)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.58</b> (0.28 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.51</b> (0.19 to 0.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>49%</b> (28% to 70%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>40%</b> (19% to 65%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>51</b> (30 to 72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>40</b> (19 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CA 19‐9 &gt; 1000 U/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (41)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.90</b> (0.60 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.42</b> (0.26 to 0.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>56%</b> (47% to 65%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>16%</b> (3% to 57%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>44</b> (35 to 53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>16</b> (3 to 57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS‐FNA</b> (CEA &gt; 692.8 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (20)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.80</b> (0.49 to 0.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.90</b> (0.60 to 0.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>87%</b> (50% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15%</b> (5% to 39%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13</b> (2 to 50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>15</b> (5 to 39) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>PET</b> (SUVmax &gt; 2 to 2.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 (124)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.90</b> (0.79 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.94</b> (0.81 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>93%</b> (78% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8%</b> (4% to 16%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>7</b> (2 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>8</b> (4 to 16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (139)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.87</b> (0.00 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.96</b> (0.00 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>95%</b> (0% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10%</b> (0% to 100%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>5</b> (0 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>10</b> (0 to 100) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear or high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (189)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.69</b> (0.44 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.93</b> (0.43 to 1.00) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>89%</b> (35% to 99%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21%</b> (12% to 36%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (1 to 65) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>21</b> (12 to 36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) (median pre‐test probability: 21%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (51)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.77</b> (0.50 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.89</b> (0.76 to 0.96) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>67%</b> (43% to 84%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>7%</b> (3% to 16%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>33</b> (16 to 57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>7</b> (3 to 16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Unclear</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (46)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.50</b> (0.22 to 0.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.95</b> (0.83 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>72%</b> (36% to 92%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13%</b> (7% to 22%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>28</b> (8 to 64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>13</b> (7 to 22) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) (median pre‐test probability: 59%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CT</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 (106)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.83</b> (0.68 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.83</b> (0.64 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>89%</b> (56% to 98%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>33%</b> (18% to 52%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>11</b> (2 to 44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>33</b> (18 to 52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MRI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (71)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.80</b> (0.58 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.81</b> (0.53 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>86%</b> (67% to 95%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>27%</b> (13% to 47%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>14</b> (5 to 33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>27</b> (13 to 47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="11" rowspan="1" valign="top"> <p><b> Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign (median pre‐test probability: 43%)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>EUS</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 (70)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.97</b> (0.83 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>0.40</b> (0.26 to 0.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>55%</b> (48% to 61%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6%</b> (1% to 31%) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>45</b> (39 to 52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>6</b> (1 to 31) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>High</b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>*Post‐test probability was calculated at the median pre‐test probability.</p> <p>Abbreviations:</p> <p>CA 19‐9: carbohydrate antigen 19‐9<br/> CEA: carcinoembryonic antigen<br/> CI: confidence interval<br/> CT: computed tomography<br/> EUS: endoscopic ultrasound<br/> FNA: fine‐needle aspiration<br/> MRI: magnetic resonance imaging<br/> PET: positron emission tomography<br/> SUVmax: maximum standardised uptake values </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Imaging modalities for characterising focal pancreatic lesions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010213-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">QUADAS‐2 classification</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Domain</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Signalling question</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Signalling question</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Signalling question</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Risk of bias</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> Concerns for <br/> applicability</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>1: Patient sampling</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a consecutive or random sample of patients enrolled?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was a case‐control design avoided?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did the study avoid inappropriate exclusions?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the selection of participants have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Are there concerns that the included participants and setting do not match the review question? </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: all consecutive patients or random sample of patients with focal pancreatic lesions were enrolled </p> <p>No: selected patients were enrolled</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: case‐control design was avoided</p> <p>No: case‐control design was not avoided</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: the study avoided inappropriate exclusions (i.e. difficult‐to‐diagnose patients)</p> <p>No: the study excluded patients inappropriately</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 signalling question</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low concern: the selected participants represent the patients in whom the tests will be used in clinical practice (please see diagnostic pathway (<a href="#CD010213-fig-0001">Figure 1</a>)) </p> <p>High concern: there is high concern that participant selection was performed in such a way that the included participants did not represent the patients in whom the tests will be used in clinical practice </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>2: Index test(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the index test results interpreted without knowledge of the results of the reference standard? </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>If a threshold was used, was it prespecified?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the conduct or interpretation of the index test have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Are there concerns that the index test, its conduct, or its interpretation differ from the review question? </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: index test results were interpreted without knowledge of the results of the reference standard </p> <p>No: index test results were interpreted with knowledge of the results of the reference standard </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: if the criteria for a positive test were prespecified</p> <p>No: if the criteria for a positive test were not prespecified</p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 of the 2 signalling questions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>High concern: there is high concern that the conduct or interpretation of the index test differs from the way it is likely to be used in clinical practice </p> <p>Low concern: there is low concern that the conduct or interpretation of the index test differs from the way it is likely to be used in clinical practice </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>3: Target condition and reference standard(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Is the reference standard likely to classify the target condition correctly?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were the reference standard results interpreted without knowledge of the results of the index tests? </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the reference standard, its conduct, or its interpretation have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Are there concerns that the target condition as defined by the reference standard does not match the review question? </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: histopathological examination of the entire lesion by surgical resection</p> <p>No: histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) and clinical follow‐up by a doctor (with or without sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months and for a maximum period of 24 months </p> <p>Unclear: this was not clear from the report. Such studies will be excluded</p> <p>Yes: reference standard results were interpreted without knowledge of the results of the index test </p> <p>No: reference standard results were interpreted with knowledge of the results of the index test </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 of the 2 signalling questions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low concern: histopathological examination of the entire lesion by surgical resection</p> <p>High concern: histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) and clinical follow‐up by a doctor (with or without sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months and for a maximum period of 24 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>4: Flow and timing</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Was there an appropriate interval between index test and reference standard?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Did all patients receive the same reference standard?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Were all patients included in the analysis?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Could the patient flow have introduced bias?</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes:</p> <p>histopathological examination of the entire lesion (gold standard) ‐ performed within 2 months (chosen arbitrarily). </p> <p>Histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) performed within 2 months and clinical follow‐up (including sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months </p> <p>No:</p> <p>the histopathological examination was performed beyond 2 months of the index tests.</p> <p>The clinical follow‐up (including sequential follow‐up imaging) was performed less than 6 months after the index test, because some tumours may be slow‐growing </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: histopathological examination of the entire lesion by surgical resection</p> <p>No: histopathological examination (irrespective of how the tissues were obtained for histopathological examination) in patients with positive test (for cancerous or precancerous lesions) and clinical follow‐up by a doctor (with or without sequential follow‐up with imaging) of all patients with negative test for a period of at least 6 months and for a maximum period of 24 months </p> <p>Unclear: this was not clear from the report. Such studies will be excluded</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes: all patients meeting the selection criteria (selected participants) were included in the analysis, or data on all of the selected participants were available so that a 2 x 2 table including all selected participants could be constructed </p> <p>No: not all patients meeting the selection criteria were included in the analysis, or the 2 x 2 table could not be constructed using data on all selected participants </p> <p>Unclear: this was not clear from the report</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low risk: 'yes' for all signalling questions</p> <p>High risk: 'no' or 'unclear' for at least 1 signalling question</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">QUADAS‐2 classification</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010213-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary sensitivity and specificity of different tests for different target conditions</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Comparison</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name of test</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sensitivity</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Specificity</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign or precancerous</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (95% CI 0.60 to 0.91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.85 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign or precancerous</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 500 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.70 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33 (95% CI 0.12 to 0.65)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign or precancerous</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET<br/> (criteria unspecified) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (95% CI 0.73 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.72 to 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (95% CI 0.84 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.53 (95% CI 0.31 to 0.74)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (95% CI 0.07 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.91 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET (criteria unspecified)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.80 to 0.97)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.65 (95% CI 0.39 to 0.85)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET (SUVmax &gt; 3.5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (95% CI 0.87 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (95% CI 0.43 to 0.78)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98 (95% CI 0.00 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 (95% CI 0.02 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80 (95% CI 0.58 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (95% CI 0.57 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.74 to 0.98)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.60 (95% CI 0.31 to 0.83)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA (cytology)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.73 (95% CI 0.01 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (95% CI 0.15 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 50 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.29 (95% CI 0.08 to 0.64)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25 (95% CI 0.05 to 0.70)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET<br/> (SUVmax 2.4) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (95% CI 0.74 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.69 to 0.99)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (95% CI 0.45 to 0.76)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (95% CI 0.39 to 0.84)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.69 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (95% CI 0.58 to 0.96)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (95% CI 0.45 to 0.94)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.61 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.66 (95% CI 0.03 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.73 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.57 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.64 (95% CI 0.48 to 0.78)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (95% CI 0.50 to 0.87)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (95% CI 0.81 to 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.75 (95% CI 0.30 to 0.95)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.77 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (95% CI 0.74 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.83 to 0.96)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.47 (95% CI 0.24 to 0.70)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (95% CI 0.32 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 200 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.58 (95% CI 0.28 to 0.83)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.51 (95% CI 0.19 to 0.81)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CA 19‐9 &gt; 1000 U/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (95% CI 0.60 to 0.98)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.42 (95% CI 0.26 to 0.59)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS‐FNA<br/> (CEA &gt; 692.8 ng/mL) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80 (95% CI 0.49 to 0.94)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (95% CI 0.60 to 0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PET<br/> (SUVmax &gt; 2 to 2.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (95% CI 0.79 to 0.96)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (95% CI 0.81 to 0.99)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (95% CI 0.00 to 1.00)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (95% CI 0.00 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (95% CI 0.44 to 0.86)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (95% CI 0.43 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (95% CI 0.50 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (95% CI 0.76 to 0.96)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 (95% CI 0.22 to 0.78)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (95% CI 0.83 to 0.99)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (95% CI 0.68 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (95% CI 0.64 to 0.93)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MRI</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.80 (95% CI 0.58 to 0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.81 (95% CI 0.53 to 0.95)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) or benign </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>EUS</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.97 (95% CI 0.83 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.40 (95% CI 0.26 to 0.55)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cystic lesion subgroup analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign ‐ EUS‐FNA (cytology)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50 (95% CI 0.19 to 0.81)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.84 to 1.00)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cystic lesion subgroup analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cancerous versus benign ‐ PET<br/> (SUVmax &gt; 3.5) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (95% CI 0.87 to 0.99)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (95% CI 0.43 to 0.78)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cystic lesion subgroup analysis</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Precancerous or cancerous versus benign ‐ EUS‐FNA<br/> (cytology) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.43 (95% CI 0.19 to 0.71)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (95% CI 0.74 to 1.00)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>CA 19‐9: carbohydrate antigen 19‐9<br/> CEA: carcinoembryonic antigen<br/> CI: confidence interval<br/> CT: computed tomography<br/> EUS: endoscopic ultrasound<br/> FNA: fine‐needle aspiration<br/> MRI: magnetic resonance imaging<br/> PET: positron emission tomography<br/> SUVmax: maximum standardised uptake values </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary sensitivity and specificity of different tests for different target conditions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/full#CD010213-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010213-tbl-0004"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p>Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">1 Cancerous versus benign or precancerous ‐ EUS‐FNA (cytology) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">2 Cancerous versus benign or precancerous ‐ EUS‐FNA (CEA &gt; 500 ng/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">3 Cancerous versus benign or precancerous ‐ PET <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">4 Cancerous versus benign ‐ EUS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">5 Cancerous versus benign ‐ EUS‐FNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">6 Cancerous versus benign ‐ PET <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">7 Cancerous versus benign ‐ PET (SUVmax &gt; 3.5) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">8 Cancerous versus benign ‐ CT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">9 Cancerous versus benign ‐ MRI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">10 Precancerous or cancerous versus benign ‐ EUS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">11 Precancerous or cancerous versus benign ‐ EUS‐FNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">12 Precancerous or cancerous versus benign ‐ EUS‐FNA (CEA &gt; 50 ng/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">13 Precancerous or cancerous versus benign ‐ PET (SUVmax &gt; 2.4) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">14 Precancerous or cancerous versus benign ‐ CT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">15 Precancerous or cancerous versus benign ‐ MRI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">16 Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">17 Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS‐FNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">18 Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ EUS‐FNA (CEA &gt; 200 ng/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">19 Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ CT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">20 Cancerous (invasive carcinoma) versus precancerous (dysplasia) ‐ MRI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">21 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>196</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">22 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">23 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CEA &gt; 200 ng/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">24 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CA 19‐9 &gt; 1000 U/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">25 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ EUS‐FNA (CEA &gt; 692.8 ng/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">26 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ PET (SUVmax 2 to 2.5) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">27 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ CT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">28 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) ‐ MRI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">29 Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ EUS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">30 Cancerous (invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ CT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">31 Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ CT <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">32 Precancerous or cancerous (intermediate‐ or high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐grade dysplasia) ‐ MRI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">33 Cancerous (high‐grade dysplasia or invasive carcinoma) versus precancerous (low‐ or intermediate‐grade dysplasia) or benign ‐ EUS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">34 Cystic lesion subgroup analysis ‐ Cancerous versus benign ‐ EUS‐FNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>26</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">35 Cystic lesion subgroup analysis ‐ Cancerous versus benign ‐ PET <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">36 Cystic lesion subgroup analysis ‐ Precancerous or cancerous versus benign ‐ EUS‐FNA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010213.pub2/references#CD010213-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010213.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010213-note-0001">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010213-note-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010213-note-0007">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010213\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010213\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010213\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010213\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010213\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Ko3zGe0H&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010213.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010213.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010213.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010213.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010213.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726089153"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010213.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726089157"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010213.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e8b1addc69379',t:'MTc0MDcyNjA4OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 